Compound_CID,Name,Synonyms,Molecular_Weight,Molecular_Formula,Polar_Area,Complexity,XLogP,Heavy_Atom_Count,H-Bond_Donor_Count,H-Bond_Acceptor_Count,Rotatable_Bond_Count,InChI,SMILES,InChIKey,IUPAC_Name,Exact_Mass,Monoisotopic_Mass,Charge,Covalent_Unit_Count,Isotopic_Atom_Count,Total_Atom_Stereo_Count,Defined_Atom_Stereo_Count,Undefined_Atom_Stereo_Count,Total_Bond_Stereo_Count,Defined_Bond_Stereo_Count,Undefined_Bond_Stereo_Count,Linked_PubChem_Literature_Count,Linked_PubChem_Patent_Count,Linked_PubChem_Patent_Family_Count,MeSH_Headings,Annotation_Content,Annotation_Type_Count,Linked_BioAssays,Create_Date,Data_Source,Data_Source_Category,Tagged_by_PubChem
176870,Erlotinib,"Erlotinib|183321-74-6|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|Tarceva|4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-|Erlotinib free base|Erlotinib Base|OSI-774|Erlotinib [INN]|erlotinibum|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|UNII-J4T82NDH7E|J4T82NDH7E|DTXSID8046454|Erlotinib, Free Base|HSDB 8082|OSI 744|CHEBI:114785|CP-358,774|183321-74-6 (free base)|MFCD02089651|CHEMBL553|RG-1415|[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE|CP-358774|DTXCID6026454|CP-35877401|NSC 718781|R 1415|R-1415|Erlotinib (INN)|NCGC00164574-01|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib(Tarceva)|1429636-49-6|CAS-183321-74-6|Erlotinib [INN:BAN]|SR-05000001460|CP358774|Erotinib|(6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl)-(3-ethynylphenyl)amine|(6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine|nchembio866-comp3|Erlotinib free base?|Erlotinib (Standard)|Kinome_3317|n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride|ERLOTINIB [MI]|ERLOTINIB [VANDF]|ERLOTINIB [WHO-DD]|SCHEMBL8413|ERLOTINIB [EMA EPAR]|BDBM5446|cid_176870|GTPL4920|L01XE03|AAKJLRGGTJKAMG-UHFFFAOYSA-N|HMS2089F05|HMS3244M19|HMS3244M20|HMS3244N19|HMS3295A19|HMS3713C22|HMS3745M05|Tox21_112202|AC-399|HY-50896R|NSC800097|s7786|STK623143|AKOS000282911|Tox21_112202_1|CCG-220420|CS-0620|DB00530|NSC-800097|Ro-508231|SB16916|SDCCGSBI-0634409.P005|NCGC00164574-03|NCGC00164574-05|NCGC00164574-06|NCGC00164574-14|NCGC00164574-25|AS-35132|BCB03_000783|BE164419|HY-50896|SY028059|NS00006169|D07907|EN300-708808|K00241|AB01273955-01|AB01273955-02|AB01273955-03|Q418369|SR-05000001460-1|SR-05000001460-2|SR-05000001460-3|SR-05000001460-6|BRD-K70401845-001-15-7|BRD-K70401845-003-04-7|BRD-K70401845-003-09-6|Z2588038919|4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; Tarceva",393.400,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,AAKJLRGGTJKAMG-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",393.16885622,393.16885622,0,1,0,0,0,0,0,0,0,16775,79912,20969,Erlotinib Hydrochloride,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,514|880|1433|1469|1471|1479|1487|1490|1688|1726|1727|1728|1729|1731|1732|1742|1766|1768|2165|2528|2546|2551|2662|7892|68106|69416|69892|91107|201868|202680|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607|256608|256609|256610|256611|256612|256613|256614|256615|256616|256617|256618|256619|256620|256621|256622|256623|256624|256625|256626|256627|256628|256629|256630|256631|256632|256633|256634|256635|256636|256637|256638|256639|256640|256641|256642|256643|256644|256645|256646|256647|256648|256649|256650|256651|256652|256653|256654|256655|256656|256657|256658|256659|256660|256661|256662|256663|256664|256665|256666|256667|256668|256669|256670|256671|256672|256673|256674|256675|256676|256677|260895|260896|260898|260903|310063|313401|313402|313405|360729|360730|360731|360733|360734|360735|360736|360737|360738|360937|360939|371183|381969|381970|381971|381972|383024|383025|383026|383027|383028|383029|383030|383031|383032|383033|383034|383035|383036|383037|383038|383039|383040|383041|383042|383043|383044|383045|383046|383047|383048|383050|383051|383052|383053|383054|383055|383056|383057|383058|383059|383060|383061|383062|383063|383064|383112|383113|383114|383115|383288|383289|383290|383384|383385|383386|383387|383388|383389|383390|383391|383392|383393|383394|383395|383396|383397|383398|383399|383400|383573|383574|383575|383576|383577|383578|383579|383580|383581|383582|383583|383584|383585|383586|383587|383588|383589|383590|383591|383592|383593|383594|383595|383596|383597|383598|383599|383600|383601|383602|383603|383604|383605|383606|383607|383608|383609|383610|383611|383612|383613|383614|383615|383616|383617|383618|383619|383620|383621|383622|383623|383624|383625|383626|383627|383628|383629|383630|383631|383632|383633|383634|383635|383636|383637|383638|383639|383640|383641|383642|383643|383644|383645|383646|383647|383648|383649|383650|383651|383652|383653|383654|383859|383860|383861|383862|383863|383864|383865|383866|383867|383868|383869|383870|383871|383872|383873|383874|383875|383876|383877|383878|383879|383880|383881|383882|383883|383884|383885|383886|383887|383888|383889|383890|383891|383892|383893|383894|383895|383896|383897|383898|383899|383900|383901|383902|383903|383904|383905|383906|383907|383908|383909|383910|383911|383912|383913|383914|383915|383916|383917|383918|383919|383920|383921|383922|383923|383924|383925|383926|383927|383928|383929|383930|383931|383932|383933|383934|383935|383936|383937|383938|383939|383940|384125|384126|384127|384128|384129|384130|384131|384132|384133|384134|384135|384136|384137|384138|384139|384140|384141|384142|384143|384144|384145|384146|384147|384148|384149|384150|384151|384152|384153|384154|384155|384156|384157|384158|384159|384160|384161|384162|384163|384164|384165|384166|384167|384168|384169|384170|384171|384172|384173|384174|384175|384176|384177|384178|384179|384180|384181|384182|384183|384184|384185|384186|384187|384188|384189|384190|384191|384192|384193|384194|384195|384196|384197|384198|384199|384200|384201|384202|384203|384204|384205|384206|384365|384366|384367|384368|384369|384370|384371|384372|384373|384374|384375|384376|384377|384378|384379|384380|384381|384382|384383|384384|384385|384386|384387|384388|384389|384390|384391|384392|384393|384394|384395|384396|384397|384398|384399|384400|384401|384402|384403|384404|384405|384406|384407|384408|384409|384410|384411|384412|384413|384414|384415|384416|384417|384418|384419|384420|384421|384422|384423|384424|384425|384426|384427|384428|384429|384430|384431|384432|384433|384434|384435|384436|384437|384438|384439|384440|384441|384442|384443|384444|384445|384613|384614|384615|384616|384617|384618|384619|384620|384621|384622|384623|384624|384625|384626|384627|384628|384629|384630|384631|384632|384633|384634|384635|384636|384637|384638|384639|384640|384641|384642|384643|384644|384645|384646|384647|384648|384649|384650|384651|384652|384653|384654|384655|384656|384657|384658|384659|384660|384661|384662|384663|384664|384665|384666|384667|384668|384669|384670|384671|384672|384673|384674|384675|384676|384677|384678|384679|384680|384681|384682|384683|384684|384685|384686|384687|384688|384689|384690|384691|384692|384693|384828|384829|384830|384831|384832|384833|384834|384835|384836|384837|384838|384839|384840|384841|384842|384843|384844|384845|384846|384847|384848|384849|384850|384851|384852|384853|384854|384855|384856|384857|384858|384859|384860|384861|384862|384863|384864|384865|384866|384867|384868|384869|384870|384871|384872|384873|384874|384875|384876|384877|384878|384879|384880|384881|384882|384883|384884|384885|384886|384887|384888|384889|384890|384891|384892|384893|384894|384895|384896|384897|384898|384899|384900|384901|384902|384903|384904|384905|384906|384907|384908|384909|384910|384911|384912|384913|384914|384915|384916|385016|385017|385018|385029|385040|385041|385042|385043|385044|385045|385046|385047|385048|385049|385050|385051|385052|385053|385054|385055|385056|385057|385058|385059|385060|385061|385062|385063|385064|385065|385066|385067|385068|385069|385070|385071|385072|385073|385074|385075|385076|385077|385078|385079|385080|385081|385082|385083|385084|385085|394662|395851|395852|404304|410943|410944|435146|435147|435148|435149|435150|435151|435152|435153|435154|435155|435156|435157|435158|435159|435160|435161|435162|435163|435164|435165|435166|435167|435168|435169|435170|435171|435180|435181|435182|435183|435184|435188|435189|435190|435191|435192|435193|435194|435195|435196|435197|435198|435199|435200|435201|435202|435203|435204|435274|435275|435276|435277|435278|435279|435280|435281|435282|435283|435284|435285|435286|435287|435288|435289|435290|435291|435292|435293|435294|435295|435296|435297|435310|435311|435312|435318|435319|435320|435321|435322|435323|435324|435325|435326|435327|435328|435329|435393|435394|435395|435396|435397|435398|435399|435400|435401|435402|435403|435404|435405|435406|435407|435408|435409|435410|435411|435412|435413|435414|435415|435429|435430|435431|435432|435433|435434|435438|435439|435440|435441|435442|435443|435444|435445|435514|435515|435516|435517|435518|435519|435520|435521|435522|435523|435524|435525|435526|435527|435528|435529|435530|435531|435532|435533|435534|435545|435546|435551|435552|435553|435554|435555|435556|435557|435558|435559|435560|435561|435562|435563|435564|435644|435645|435646|435647|435648|435649|435650|435651|435652|435653|435654|435655|435656|435657|435658|435659|435660|435661|435662|435663|435664|435665|435666|435667|435674|435675|435676|435677|435678|435679|435687|435688|435689|435690|435691|435692|435693|435694|435775|435776|435777|435778|435779|435780|435781|435782|435783|435784|435785|435786|435787|435788|435789|435790|435791|435792|435793|435794|435795|435796|435797|435798|435799|435800|435801|435802|435803|435804|435805|435806|435807|435808|435821|435822|435823|435826|435827|435828|435829|435830|435831|435832|435833|435834|435835|435896|435897|435898|435899|435900|435901|435902|435903|435904|435905|435906|435907|435908|435909|435910|435911|435912|435924|435925|435926|435929|435930|435931|435932|435933|435934|435935|435936|435937|435938|435939|435940|435941|436004|436005|436006|436007|436008|436009|436010|436011|436012|436013|436014|436015|436016|436017|436018|436019|436020|436021|436022|436023|436024|436025|436032|436033|436034|436042|436043|436044|436045|436046|436047|436048|436049|436050|436051|436052|436053|436054|436055|441961|441962|441963|441964|441965|441966|441967|441995|441997|455986|456090|456091|456092|456099|456100|456101|456588|456589|456590|456593|460689|460690|460691|461251|461252|461253|461254|461255|461256|461257|461258|461259|461260|461261|461262|461263|461264|461265|461266|461267|461268|461269|461300|463638|463639|473321|473322|473323|473324|473325|473326|473327|473328|473329|473330|473523|473524|473525|474115|474116|474117|477295|481815|481817|481818|485290|488708|488709|488710|488711|488712|488713|488715|488716|488717|492036|492037|492320|492321|492322|492961|493040|493204|493206|504327|504332|504534|504749|504832|504834|504847|504865|513986|513987|513988|513990|517322|517323|517324|580189|580190|588579|588834|589039|599957|599959|602332|612769|612770|612771|612772|616546|616547|618743|618744|619785|619787|619789|619791|619792|619793|620239|620240|620243|620244|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|624768|624769|624770|624771|624772|624773|624774|624775|624776|624777|624778|624779|624780|624781|624782|624783|624784|624785|624786|624787|624788|624789|624790|624791|624792|624793|624794|624795|624796|624797|624798|624799|624800|624801|624802|624803|624804|624805|624806|624807|624808|624809|624810|624811|624812|624813|624814|624815|624816|624817|624818|624819|624820|624821|624822|624823|624824|624825|624826|624827|624828|624829|624830|624831|624832|624833|624834|624835|624836|624837|624838|624839|624840|624841|624842|624843|624844|624845|624846|624847|624848|624849|624850|624851|624852|624853|624854|624855|624856|624857|624858|624859|624860|624861|624862|624863|624864|624865|624866|624867|624868|624869|624870|624871|624872|624873|624874|624875|624876|624877|624878|624879|624880|624881|624882|624883|624884|624885|624886|624887|624888|624889|624890|62,20050326,"001Chemical|10X CHEM|1st Scientific|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accel Scientific|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acmec Biochemical|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Aladdin Scientific|AlchemyPharm|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|AppChem|Ark Pharm, Inc.|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BerrChemical|Bic Biotech|BindingDB|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|BroadPharm|Burnham Center for Chemical Genomics|CAPOT|CEGChem|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Cheminformatics Friedrich-Schiller-University Jena|ChemMol|ChemShuttle|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Crystallography Open Database (COD)|CSNpharm|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|Enamine|Ennopharm|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Fisher Drug Discovery Resource Center|ForeChem|Founder Pharma|Fragmenta|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|Innovapharm|InvivoChem|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|LGC Standards|Life Chemicals|MassBank Europe|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MedChemexpress MCE|Metabolomics Workbench|MLSMR|MolCore|Molecule Market|Molepedia|MolGenie|Molport|MuseChem|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NIAID ChemDB|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Novartis Institutes for BioMedical Research|NovoSeek|Oakwood Products|OChem|Parchem|PATENTSCOPE (WIPO)|Petrascheck Lab, The Scripps Reserach Institute, Department of  Molecular Medicine|Phion Ltd|Pi Chemicals|Probes & Drugs portal|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|PubChem Reference Collection|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|SCRIPDB|Selleck Chemicals|SGCOxCompounds|Shanghai Mathcon Pharmaceutical Co.,LTD.|Shanghai Send Pharmaceutical Technology Co., Ltd|Sigma-Aldrich|Sinfoo Biotech|SLING Consortium|SMID|Smolecule|Southern Research Institute|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|SynHet - Synthetic Heterocycles|Synthonix, Inc.|Syntree|TargetMol|THE BioTek|The Scripps Research Institute Molecular Screening Center|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tox21|ToxPlanet|Uchem Meditech|University of Kansas High Throughput Screening Laboratory|Vitas-M Laboratory|VladaChem|W&J PharmaChem|Wikidata|Wiley|Win-Win Chemical|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors|L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors
176871,Erlotinib Hydrochloride,"Erlotinib hydrochloride|183319-69-9|erlotinib HCl|Tarceva|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|OSI-774|OSI 774|Erlotinib (Hydrochloride)|CP 358774|Erlotinib HCl (OSI-744)|UNII-DA87705X9K|Erlotinib 13C6 HCl|Tarceva (Erlotinib Hydrochloride)|DA87705X9K|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)|CP-358|MFCD07781272|CP-358,774-01|CP-358774|CHEBI:53509|DTXSID10171412|Erlotinib Hydrochloride (Tarceva)|CP-358774-01|4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|NSC718781|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride|NSC-718781|6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride|183319-69-9 (HCl)|HCl, Erlotinib|ERLOTINIB HYDROCHLORIDE (MART.)|ERLOTINIB HYDROCHLORIDE [MART.]|[6,7-BIS-(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)-AMINE HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE (USP-RS)|ERLOTINIB HYDROCHLORIDE [USP-RS]|N-(3-ETHENYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride.|SMR002529980|Erlotinib hydrochloride [USAN]|Hydrochloride, Erlotinib|183319-69-9 pound not183321-74-6|C22H24ClN3O4|Erlotinib hydrochloride [USAN:INN]|Tarceva (OSI)|Tarceva (TN)|Erlotinib hydrochloride?|n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride|Erlotinib(OSI-744)|Erlotinib hydrochloride salt|erlotinib, hydrochloride salt|MLS003899192|MLS004774139|CHEMBL1079742|DTXCID7093903|NSC 718781) HCl|EX-A064|6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hcl|BCPP000238|BCP02600|Erlotinib hydrochloride (JAN/USAN)|ERLOTINIB HYDROCHLORIDE [MI]|AC-400|ERLOTINIB HYDROCHLORIDE [JAN]|HY-12008R|s1023|Erlotinib (Hydrochloride) (Standard)|AKOS015849087|BCP9000658|CCG-269002|CS-0123|FE10803|KS-1202|PB30965|SB16917|ERLOTINIB HYDROCHLORIDE [WHO-DD]|Ro-50-8231|BE164421|BP-30224|HY-12008|(CP358774|DB-011534|Erlotinib hydrochloride - Bio-X trade mark|ERLOTINIB HYDROCHLORIDE [ORANGE BOOK]|NS00076170|D04023|E-4007|EN300-123054|Q27124083|F0001-2385|Erlotinib Hydrochloride is known as a EGFR Kinase inhibitor.|Erlotinib Hydrochloride,CP-358774, OSI-774, NSC 718781|6,7-Bis-(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride|[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydrochloride|N-(3-Ethynylphenyl)-6,7-bis(1-methoxyethoxy)-4-quinazolinamine hydrochloride|N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, monohydrochloride|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-quinazolin-4-amine hydrochloride|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine monohydrochloride|Tarceva hydrochloride; Erlotinib hydrochloride; 6 ,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; N-(3-Ethyny lphenyl)6,7-bis(2-methoxyethoxy)quinazolin-4-ylamine HCl|Tarceva Hydrochloride;Erlotinib hydrochloride;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;N-(3-Ethynylphe  nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl",429.900,C22H24ClN3O4,74.700,525.000,"",30,2,7,11,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,GTTBEUCJPZQMDZ-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",429.1455339,429.1455339,0,2,0,0,0,0,0,0,0,4677,31,15,Erlotinib Hydrochloride,Biological Test Results|Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Associated Disorders and Diseases|Spectral Information|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|472048|472049|472050|472051|651821|651957|651958|652010|652017|652039|652067|652126|652257|686940|686964|687014|687016|720508|720509|720543|720582|720596|720648|720700|720702|720704|743126|743269|743445|1053197|1117264|1215757|1215758|1215759|1215760|1215761|1215762|1215763|1215764|1215765|1215766|1215767|1215768|1215769|1215770|1215771|1215772|1215773|1215774|1215775|1215776|1215777|1215778|1215779|1215780|1215781|1215782|1215783|1215784|1215785|1215786|1259318|1346378|1347120|1347162|1406661|1406663|1409598|1508598|1529834|1529835|1529836|1640020|1645758|1671463|1749710|1749711|1920062|1962016,20050326,"001Chemical|10X CHEM|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accel Scientific|Achemo Scientific Limited|Achemtek|Acmec Biochemical|Acorn PharmaTech Product List|Active Biopharma|Adooq BioScience|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alsachim|Amadis Chemical|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|AppChem|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BerrChemical|Bic Biotech|BindingDB|BioChemPartner|BioCrick|Biosynth|BOC Sciences|Boerchem|BroadPharm|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Cooke Chemical Co., Ltd|Cure First|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|Enamine|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Exclusive Chemistry Ltd|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Founder Pharma|Glentham Life Sciences Ltd.|Hairui Chemical|Hangzhou APIChem Technology|iChemical Technology USA Inc|Innovapharm|InvivoChem|ISpharm|J&H Chemical Co.,ltd|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LeadScope|LEAPCHEM|LGC Standards|Life Chemicals|MassBank of North America (MoNA)|Matrix Scientific|Mcule|MedChemexpress MCE|MLSMR|MolCore|Molecule Market|Molepedia|MolGenie|Molport|MuseChem|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|Oakwood Products|OChem|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|Prous Science Drugs of the Future|PubChem Reference Collection|RR Scientific|Santa Cruz Biotechnology, Inc.|Santagata Laboratory - Brigham and Women's Hospital and Harvard Medical School|Selleck Chemicals|Shanghai Mathcon Pharmaceutical Co.,LTD.|Sigma-Aldrich|Smolecule|Springer Nature|Starshine Chemical|Synblock Inc|SynHet - Synthetic Heterocycles|Synthonix, Inc.|Syntree|TargetMol|THE BioTek|Thieme Chemistry|Thomson Pharma|Thoreauchem|ToxPlanet|University of Kansas High Throughput Screening Laboratory|VladaChem|W&J PharmaChem|Wikidata|Win-Win Chemical|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZeroPM - Zero Pollution of Persistent, Mobile Substances",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent|C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor|C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor|C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor|D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
16045730,CP-373413,"183320-29-8|OSI-413|Erlotinib metabolite M13|2-(4-(3-Ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxyethanol|CP-373413|UNII-EBL2O556JZ|OSI-413 (free base)|EBL2O556JZ|7-(2'-Desmethyl) erlotinib|2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol|Ethanol, 2-((4-((3-ethynylphenyl)amino)-6-(2-methoxyethoxy)-7-quinazolinyl)oxy)-|CHEMBL3741490|OSI413;OSI 413;CP 373413|2-((4-((3-Ethynylphenyl)amino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethan-1-ol|SCHEMBL1507627|DTXSID10939711|BDBM50499592|NS00116691|Q27277092",379.400,C21H21N3O4,85.700,511.000,2.800,28,2,7,10,"InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(28-10-9-26-2)20(27-8-7-25)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCO,MTLKTHNRZJKPRP-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol,379.15320616,379.15320616,0,1,0,0,0,0,0,0,0,5,71,17,"",Biological Test Results|Classification|Literature|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,8,1264567|1264568|1264569|1264570|1264571|1264592,20070430,"001Chemical|10X CHEM|A2B Chem|A2Z Chemical|AA BLOCKS|Achemtek|Acorn PharmaTech Product List|AiFChem, an XtalPi Company|Ambinter|BenchChem|Bic Biotech|BindingDB|BioChemPartner|Biosynth|BLD Pharm|BOC Sciences|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|CymitQuimica|DiscoveryGate|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Human Metabolome Database (HMDB)|IBM|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LGC Standards|MolCore|MolGenie|MuseChem|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Probes & Drugs portal|PubChem Reference Collection|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
18924996,Desmethyl Erlotinib,"183320-51-6|OSI-420|Desmethyl Erlotinib|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-, hydrochloride (1:1)|Desmethyl Erlotinib (hydrochloride)|2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol;hydrochloride|OSI-420;CP-473420|CP-473420|2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol hydrochloride|2-({4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl}oxy)ethanol hydrochloride|C21H22ClN3O4|Desmethyl Erlotinib hydrochloride|OSI420 HCl|ZJ7FA2S8Q6|MLS006011273|SCHEMBL1507689|DTXSID50596524|OSI-420 (Desmethyl Erlotinib)|GLXC-10595|BCP28007|OSI-420?|s2205|AKOS025289327|CCG-268834|CS-0467|2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethan-1-ol hydrochloride|AC-32049|AS-77424|FO158697|HY-13256|SMR004703023|SW219293-1|F96184|2- ((4- ((3- Ethynylphenyl) amino) - 7- (2- methoxyethoxy) quinazolin- 6- yl) oxy) ethan- 1- ol|2-[[4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]ethanol hydrochloride|2-{[4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxy}ethan-1-ol--hydrogen chloride (1/1)|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-, hydrochloride|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-, monohydrochloride",415.900,C21H22ClN3O4,85.700,511.000,"",29,3,7,10,"InChI=1S/C21H21N3O4.ClH/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21;/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24);1H",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO.Cl,BUOXOWNQZVIETJ-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol;hydrochloride,415.1298839,415.1298839,0,2,0,0,0,0,0,0,0,27,549,83,"",Biological Test Results|Interactions and Pathways|Classification|Literature|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,7,1508598,20071204,"001Chemical|10X CHEM|1st Scientific|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbovChem LLC|Accel Scientific|Achemtek|Adooq BioScience|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Aladdin Scientific|Alsachim|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|ApexBio Technology|AppChem|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|Bic Biotech|BioChemPartner|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Clearsynth|Cure First|CymitQuimica|DC Chemicals|eMolecules|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Glixx Labs Inc|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Inhibitor 2|InvivoChem|J&H Chemical Co.,ltd|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|Mcule|MedChemexpress MCE|MLSMR|MolCore|Molecule Market|Molport|MuseChem|PATENTSCOPE (WIPO)|Petrascheck Lab, The Scripps Reserach Institute, Department of  Molecular Medicine|Pharmacore Co., Limited|Probes & Drugs portal|Race Chemical|RR Scientific|Selleck Chemicals|Smolecule|Starshine Chemical|SureChEMBL|Syncom|SynHet - Synthetic Heterocycles|TargetMol|THE BioTek|Thomson Pharma|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,""
10317566,2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol,"183321-86-0|Desmethyl Erlotinib|OSI-420, Free Base (Desmethyl Erlotinib)|2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol|CP 373420|Erlotinib metabolite M14|2-[[4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]ethanol|OSI420|X78J9Z28DQ|2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-|CP-373420|2-(4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxyethanol|Ethanol, 2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy)-6-quinazolinyl)oxy)-|183321-86-0 pound>>183320-51-6|2-({4-[(3-ETHYNYLPHENYL)AMINO]-7-(2-METHOXYETHOXY)QUINAZOLIN-6-YL}OXY)ETHANOL|OSI 420|Erlotinib, 6-O-Desmethyl-|UNII-X78J9Z28DQ|OSI-420 FREE BASE|SCHEMBL1507409|CHEMBL3186743|BCPP000136|BCP02398|EX-A064-1|HY-13256A|2-(4-(3-ethynylphenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)ethanol|AKOS025289326|BCP9001036|SDCCGSBI-0654400.P002|NCGC00346578-01|MS-26201|CS-0003183|AB01274806-01|AB01274806_02|BRD-K73309154-003-02-8",379.400,C21H21N3O4,85.700,511.000,2.800,28,2,7,10,"InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO,KOQIAZNBAWFSQM-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol,379.15320616,379.15320616,0,1,0,0,0,0,0,0,0,10,1339,298,"",Biological Test Results|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,743344|743345|743346|743347|1224824|1224825|1224857|1224859|1224863|1259252|1259253|1259255|1259256|1259416|1259421|1296008|1296009|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347411|1409598|1508620|1508623|1508624|1508630|1640020|1645758|1645840|1645841|1645842|1645845|1645846|1645870|1645876|1645877|1671188|1671190|1671193|1671194|1745845|1749710|1749711|1845191|1845192|1918924|1918925|1918926|1918927|1918928|1918929|1918959|1918960|1918961|1918962|1918963|1918964|1918965|1918966|1918967|1918968|1918970|1918971|1918972|1918973|1918974|1918975|1918976|1918977|1918978|1918979|1918980|1918981|1918982|1918983|1918984|1918985|1918987|1918988|1918989|1919863|1919864|1919865|1919866|1919867|1919868|1919869|1919870|1919871|1919872|1919873|1919874|1963576|1963596|1963597,20061025,"001Chemical|10X CHEM|1st Scientific|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|Accel Scientific|Achemtek|Acorn PharmaTech Product List|Adooq BioScience|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Aladdin Scientific|Alichem|Alsachim|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|AppChem|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BenchChem|Bic Biotech|BioChemPartner|Biocore|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Clearsynth|Clinivex|Cooke Chemical Co., Ltd|Cure First|CymitQuimica|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|eMolecules|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Glixx Labs Inc|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Human Metabolome Database (HMDB)|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Inhibitor 2|InvivoChem|J&H Chemical Co.,ltd|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LGC Standards|Matrix Scientific|Mcule|MedChemexpress MCE|MLSMR|MolCore|Molecule Market|MolGenie|Molport|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NIH/NCATS RNAi|PATENTSCOPE (WIPO)|Petrascheck Lab, The Scripps Reserach Institute, Department of  Molecular Medicine|Pharmacore Co., Limited|Probes & Drugs portal|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|Selleck Chemicals|Smolecule|Southern Research Institute|Starshine Chemical|SureChEMBL|Syncom|SynHet - Synthetic Heterocycles|TargetMol|THE BioTek|Thomson Pharma|Tractus|Uchem Meditech|UCSC Chemical Screening Center|University of Kansas High Throughput Screening Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,""
44263854,Tarceva,"Tarceva|OSI-774|NSC 718781|erlotinibhydrochloride|n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride|SCHEMBL18562|AKOS025395679",429.900,C22H24ClN3O4,74.700,525.000,"",30,2,8,11,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H",[H+].COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.[Cl-],GTTBEUCJPZQMDZ-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydron;chloride",429.1455339,429.1455339,0,3,0,0,0,0,0,0,0,4541,13063,2545,Erlotinib Hydrochloride,Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Patents|Pharmacology and Biochemistry,6,"",20091119,"1st Scientific|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Ambeed|Angene Chemical|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BLD Pharm|ChEBI|Chembase.cn|CSNpharm|DiscoveryGate|Google Patents|King Scientific|Molport|Parchem|Phion Ltd|Race Chemical|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,D000970 - Antineoplastic Agents|D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
135409305,"6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one","179688-29-0|6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4(3H)-ONE|6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone|6,7-Bis(2-methoxyethoxy)-3,4-dihydroquinazolin-4-one|4(3H)-Quinazolinone, 6,7-bis(2-methoxyethoxy)-|6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone|6,7-Bis(2-Methoxyethoxy)Quinazolin-4(1H)-One|CP-380736|6,7-Bis(2-methoxyethoxy)-3H-quinazolin-4-one|6,7-bis(2-methoxyethoxy)-1H-quinazolin-4-one|B5ASH28MRM|MFCD02678087|6,7-bis-(2-Methoxyethoxy)-quinazolin-4(3h)-one|6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-OL|4(1H)-Quinazolinone, 6,7-bis(2-methoxyethoxy)-|6,7-bis(2-methoxyethoxy)-4(3H)-Quinazolinone; 4(1H)-Quinazolinone, 6,7-bis(2-methoxyethoxy)- (9CI); 6,7-Bis(2-methoxyethoxy)-3,4-dihydroquinazolin-4-one; 6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone; 6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one; 6,7-Di(2-methoxyethoxy)-3,4-dihydroquinazolin-4-one|Erlotinib Lactam Impurity|UNII-B5ASH28MRM|PF-00520893|SCHEMBL263796|CHEMBL1713411|DTXSID00384594|CHEBI:228775|PMQWTUWLIGJTQD-UHFFFAOYSA-N|HMS1662H06|HMS3260F19|BCP02605|Tox21_500189|CCG-43571|AKOS000282901|AKOS025402163|AC-5914|AC-6916|CS-W002950|FB18678|FD16019|HY-W002950|SB67315|NCGC00260874-01|AS-11435|CP380736|SY033245|6,7-Bis(2-methoxyethoxy)-4-quinazolinol|6,7-bis(2-methoxyethoxy)-4-quinazolinone|6,7-bis(2-methoxyethoxy)quinazolin-4-one|A3986|B4270|6,7-Bis(2-methoxyethoxy)-4-hydroxyquinazoline|6,7-bis-(2-methoxyethoxy)-4(3H)quinazolinone|CP-380736, >=98% (HPLC)|6,7-bis-(2-methoxyethoxy)-4 (3H) quinazolinone|A1-01728|SR-01000633479-1|SR-01000633479-2|6,7-Di(2-methoxyethoxy)-3,4-dihydroquinazolin-4-one;6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one;CP-380736|605-867-4",294.300,C14H18N2O5,78.400,363.000,0.400,21,1,6,8,"InChI=1S/C14H18N2O5/c1-18-3-5-20-12-7-10-11(15-9-16-14(10)17)8-13(12)21-6-4-19-2/h7-9H,3-6H2,1-2H3,(H,15,16,17)",COCCOC1=C(C=C2C(=C1)C(=O)NC=N2)OCCOC,PMQWTUWLIGJTQD-UHFFFAOYSA-N,"6,7-bis(2-methoxyethoxy)-3H-quinazolin-4-one",294.12157168,294.12157168,0,1,0,0,0,0,0,0,0,11,153,52,"",Biological Test Results|Classification|Literature|Patents|Safety and Hazards|Biological Test Results: Active,6,811|833|1044|1792|1823|2165|2291|434982|485350|485395|492967|493033|504770|540299|588519|651828|652031|720641|720717|1159607|1224818|1224819|1224820|1224821|1224822|1224823|1224857|1224905|1259370|1347053|1347055|1347057|1347058|1347059|1347074|1347080|1347143|1347151|1347384|1347405|1347410|1508618|1645843|1645873|1745853|1794808|1794843|1845191|1845192|1918969,20190115,"001Chemical|10X CHEM|1st Scientific|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A1 BioChem Labs|A2B Chem|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accel Scientific|Accela ChemBio Inc.|Achemo Scientific Limited|Acmec Biochemical|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Aladdin Scientific|AlchemyPharm|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|AppChem|Ark Pharm, Inc.|Aromalake Chemical|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BePharm Ltd.|Bic Biotech|BioChemPartner|Biosynth|BLD Pharm|BOC Sciences|Boronpharm|CAPOT|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Impex|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|ChemWise|Clearsynth|Clinivex|Collaborative Drug Discovery, Inc.|Combi-Blocks|Cooke Chemical Co., Ltd|CymitQuimica|Day Biochem|DC Chemicals|DiscoveryGate|eMolecules|eNovation Chemicals|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Founder Pharma|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|Hefei Hirisun Pharmatech Co., Ltd|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc|InvivoChem|ISpharm|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|King Scientific|LabNetwork, a WuXi AppTec Company|labseeker|Lan Pharmatech|LEAPCHEM|LGC Standards|Matrix Scientific|Mcule|MedChemexpress MCE|MolCore|Molepedia|MolGenie|Molport|MuseChem|NextBio|NextMove Software|NORMAN Suspect List Exchange|Oakwood Products|OChem|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|PubChem Reference Collection|Race Chemical|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Sigma-Aldrich|Sinfoo Biotech|Small Molecule Screening Facility, UW Madison|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|Synblock Inc|SynHet - Synthetic Heterocycles|Syntech Labs|Synthonix, Inc.|TCI (Tokyo Chemical Industry)|Tetrahedron Scientific Inc|THE BioTek|The Scripps Research Institute Molecular Screening Center|Thieme Chemistry|Thomson Pharma|Thoreauchem|Tox21|ToxPlanet|TripleBond|University of Kansas High Throughput Screening Laboratory|VWR, Part of Avantor|Win-Win Chemical|Wubei-Biochem|Wutech|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|Yuhao Chemical|ZINC|Zoeller Lab, School of Medicine, Boston University",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,""
71750333,4-Methyl Erlotinib Hydrochloride,"4-Methyl Erlotinib Hydrochloride|1346601-52-2|4-Methyl erlotinib|N-(3-ETHYNYL-4-METHYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE|ZC8GRP8M2B|SCHEMBL23264520|BDBM582529|PD018712|HY-129510|CS-0106117|US11524945, Compound Erlotinib-4-methylphenyl analog (E4ME)|4-Quinazolinamine, N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)-|N-(3-Ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine",407.500,C23H25N3O4,74.700,554.000,3.700,30,1,7,11,"InChI=1S/C23H25N3O4/c1-5-17-12-18(7-6-16(17)2)26-23-19-13-21(29-10-8-27-3)22(30-11-9-28-4)14-20(19)24-15-25-23/h1,6-7,12-15H,8-11H2,2-4H3,(H,24,25,26)",CC1=C(C=C(C=C1)NC2=NC=NC3=CC(=C(C=C32)OCCOC)OCCOC)C#C,PENVNSXCNXIPIF-UHFFFAOYSA-N,"N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",407.18450629,407.18450629,0,1,0,0,0,0,0,0,0,0,5,3,"",Biological Test Results|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,4,1919092,20131101,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|Ambinter|AstaTech, Inc.|BenchChem|BindingDB|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|Clearsynth|CymitQuimica|eMolecules|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|Human Metabolome Database (HMDB)|IBM|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|LGC Standards|Mcule|MedChemexpress MCE|MolCore|Molport|MuseChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
58735307,"6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine","6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine|1145671-52-8|Desethynyl Erlotinib|CHEMBL4851189|6,7-Bis(2-methoxyethoxy)-N-phenyl4-quinazolinamine|SCHEMBL20805304|BDBM50574865|F19498|Desethynyl Erlotinib; 4-Quinazolinamine, 6,7-bis(2-methoxyethoxy)-N-phenyl-; 6,7-Bis(2-methoxyethoxy)-N-phenyl-4-quinazolinamine; 6,7-Bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine; Desethynyl Erlotinib; Desethynylerlotinib",369.400,C20H23N3O4,74.700,409.000,3.100,27,1,7,10,"InChI=1S/C20H23N3O4/c1-24-8-10-26-18-12-16-17(13-19(18)27-11-9-25-2)21-14-22-20(16)23-15-6-4-3-5-7-15/h3-7,12-14H,8-11H2,1-2H3,(H,21,22,23)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC=C3)OCCOC,FIEPRWDRWNAAFJ-UHFFFAOYSA-N,"6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine",369.16885622,369.16885622,0,1,0,0,0,0,0,0,0,1,14,6,"",Biological Test Results|Classification|Literature|Patents,4,1773372,20120819,"A2B Chem|AA BLOCKS|AiFChem, an XtalPi Company|Alichem|AstaTech, Inc.|BenchChem|BindingDB|BLD Pharm|BOC Sciences|ChEMBL|Clearsynth|Combi-Blocks|CymitQuimica|EvitaChem|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LGC Standards|MolGenie|Molport|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|SCRIPDB|Sigma-Aldrich|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
74963268,CP-394356,"882420-22-6|Erlotinib metabolite M16|4'-Hydroxy erlotinib|3OAQ9M99Y2|CP-394356|UNII-3OAQ9M99Y2|4-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)-2-ethynyl-phenol|Phenol, 4-((6,7-bis(2-methoxyethoxy)-4-quinazolinyl)amino)-2-ethynyl-|4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]-2-ethynylphenol|SCHEMBL3875759|NS00116993|Q27894558",409.400,C22H23N3O5,95.000,556.000,3.000,30,2,8,11,"InChI=1S/C22H23N3O5/c1-4-15-11-16(5-6-19(15)26)25-22-17-12-20(29-9-7-27-2)21(30-10-8-28-3)13-18(17)23-14-24-22/h1,5-6,11-14,26H,7-10H2,2-3H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)O)C#C)OCCOC,NEEHJGWAKAIBAR-UHFFFAOYSA-N,"4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]-2-ethynylphenol",409.16377084,409.16377084,0,1,0,0,0,0,0,0,0,3,2,1,"",Classification|Literature|Patents|Pharmacology and Biochemistry,4,"",20140701,"A2B Chem|AA BLOCKS|Acorn PharmaTech Product List|BenchChem|BOC Sciences|ChemIDplus|CymitQuimica|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EvitaChem|FDA Global Substance Registration System (GSRS)|IBM|LGC Standards|MolGenie|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|PubChem Reference Collection|Starshine Chemical|SureChEMBL|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
42609709,[11C]Tarceva,"[11C]Erlotinib|[11C]Tarceva|[11C]OSI-774|[11C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine",406.500,C23H25N3O4,74.700,540.000,3.700,30,1,7,12,"InChI=1S/C23H25N3O4/c1-4-17-7-6-8-18(13-17)26-23-19-14-21(30-12-10-28-5-2)22(29-11-9-27-3)15-20(19)24-16-25-23/h1,6-8,13-16H,5,9-12H2,2-3H3,(H,24,25,26)/i2-1",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCOC[11CH3],CGGCTVKVZKTIME-JVVVGQRLSA-N,6-(2-(211C)ethoxyethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine,406.1959389,406.1959389,0,1,1,0,0,0,0,0,0,0,6,2,"",Interactions and Pathways|Classification|Drug and Medication Information|Patents,4,"",20090618,Google Patents|Molecular Imaging and Contrast Agent Database (MICAD)|MolGenie|Wikidata,Curation Efforts|Governmental Organizations|Research and Development,""
18925065,4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinol,183322-38-5|4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinol|Des-6-methoxyethanol Erlotinib|4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-ol|SCHEMBL4348479|IHA32238|DB-425784|NS00116706|4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-ol,335.400,C19H17N3O3,76.500,466.000,3.100,25,2,6,7,"InChI=1S/C19H17N3O3/c1-3-13-5-4-6-14(9-13)22-19-15-10-17(23)18(25-8-7-24-2)11-16(15)20-12-21-19/h1,4-6,9-12,23H,7-8H2,2H3,(H,20,21,22)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)O,PKUSDEYOSFKCTN-UHFFFAOYSA-N,4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-ol,335.12699141,335.12699141,0,1,0,0,0,0,0,0,0,3,20,6,"",Classification|Literature|Patents|Pharmacology and Biochemistry,4,"",20071204,"001Chemical|A2B Chem|AA BLOCKS|BenchChem|Biosynth|BLD Pharm|ChemSpider|CymitQuimica|Debye Scientific Co., Ltd|EvitaChem|Google Patents|Hairui Chemical|IBM|MolCore|MolGenie|NextMove Software|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Smolecule|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
11599950,Gemcitabine-erlotinib regimen,Gemcitabine-erlotinib regimen|Gemcitabine-erlotinib|Gemcitabine / erlotinib|SCHEMBL3424479|Erlotinib regimen with Gemcitabine|KKZRPIKZBFQAKR-YPWTWYSKSA-N|S900005540,656.600,C31H34F2N6O8,183.000,951.000,"",47,4,13,13,"InChI=1S/C22H23N3O4.C9H11F2N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t;4-,6-,7-/m.1/s1",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,KKZRPIKZBFQAKR-YPWTWYSKSA-N,"4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",656.24061839,656.24061839,0,2,0,3,3,0,0,0,0,0,242,46,"",Classification|Literature|Patents,3,"",20061026,"ChemIDplus|ChemSpider|ECI Group, LCSB, University of Luxembourg|Google Patents|MolGenie|NextBio|SureChEMBL|Thomson Pharma",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
44625620,Erlotinib C-11,"Erlotinib C-11|92101ZTI3Q|UNII-92101ZTI3Q|1137584-37-2|4-Quinazolinamine, N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-6-(2-(methoxy-11C)ethoxy)-|CHEMBL5220042",392.400,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)/i2-1",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO[11CH3],AAKJLRGGTJKAMG-JVVVGQRLSA-N,N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-6-(2-(111C)methoxyethoxy)quinazolin-4-amine,392.1802888,392.1802888,0,1,1,0,0,0,0,0,0,1,0,0,"",Biological Test Results|Classification|Literature,3,1917346|1917351,20100301,ChEMBL|ChemIDplus|DiscoveryGate|FDA Global Substance Registration System (GSRS)|MolGenie|RR Scientific|Starshine Chemical|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
44306455,"[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-bromo-phenyl)-amine","328528-74-1|Erlotinib iMpurity 3|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-bromo-phenyl)-amine|CHEMBL63917|N-(3-BROMOPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE|949DS98TKL|N-(3-Bromophenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|BDBM50095258|CS-0163971|F19323|4-Quinazolinamine, N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)-|N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine? (Erlotinib Impurity pound(c)",448.300,C20H22BrN3O4,74.700,448.000,3.800,28,1,7,10,"InChI=1S/C20H22BrN3O4/c1-25-6-8-27-18-11-16-17(12-19(18)28-9-7-26-2)22-13-23-20(16)24-15-5-3-4-14(21)10-15/h3-5,10-13H,6-9H2,1-2H3,(H,22,23,24)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCCOC,LMNRGGOFCABQAE-UHFFFAOYSA-N,"N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",447.07937,447.07937,0,1,0,0,0,0,0,0,0,2,0,0,"",Biological Test Results|Classification|Literature,3,89523|684832,20091119,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Acorn PharmaTech Product List|AiFChem, an XtalPi Company|Alfa Chemistry|Alichem|Ambinter|AstaTech, Inc.|BenchChem|BindingDB|BLD Pharm|BOC Sciences|ChEMBL|Combi-Blocks|CymitQuimica|DiscoveryGate|eMolecules|EvitaChem|FDA Global Substance Registration System (GSRS)|Japan Chemical Substance Dictionary (Nikkaji)|LGC Standards|MolGenie|Molport|Sigma-Aldrich|Smolecule|Starshine Chemical|Synthink Research Chemicals|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
11206926,(Z)-1-(2-Bromovinyl)-3-nitrobenzene,(Z)-1-(2-Bromovinyl)-3-nitrobenzene|115665-66-2|1-[(Z)-2-Bromoethenyl]-3-nitrobenzene|CS-0163951|(Z)-1-(2-Bromovinyl)-3-nitrobenzene (Erlotinib Impurity pound(c),228.040,C8H6BrNO2,45.800,188.000,2.700,12,0,2,1,InChI=1S/C8H6BrNO2/c9-5-4-7-2-1-3-8(6-7)10(11)12/h1-6H/b5-4-,C1=CC(=CC(=C1)[N+](=O)[O-])/C=C\Br,YOTXPVFRAUVUQD-PLNGDYQASA-N,1-[(Z)-2-bromoethenyl]-3-nitrobenzene,226.95819,226.95819,0,1,0,0,0,0,1,1,0,2,1,1,"",Literature|Patents|Spectral Information,3,"",20061026,"AbaChemScene|Alichem|Ambeed|BenchChem|BePharm Ltd.|BLD Pharm|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|OXCHEM CORPORATION|RR Scientific|Smolecule|Starshine Chemical|Thieme Chemistry|Thomson Pharma|ZINC",Chemical Vendors|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
6710785,"N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine","299912-61-1|N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|Tetrahydro Erlotinib|N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|4-Quinazolinamine,N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)-|KBioSS_002494|SCHEMBL5669539|CHEMBL1699464|NUQUOVYZADJDTI-UHFFFAOYSA-N|ZLA91261|SR-02000000197|SR-02000000197-1",397.500,C22H27N3O4,74.700,456.000,3.900,29,1,7,11,"InChI=1S/C22H27N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h5-7,12-15H,4,8-11H2,1-3H3,(H,23,24,25)",CCC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OCCOC)OCCOC,NUQUOVYZADJDTI-UHFFFAOYSA-N,"N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",397.20015635,397.20015635,0,1,0,0,0,0,0,0,0,0,47,13,"",Biological Test Results|Classification|Patents,3,2165,20060605,"001Chemical|10X CHEM|A2B Chem|AbaChemScene|ABI Chem|AiFChem, an XtalPi Company|AstaTech, Inc.|BenchChem|Biosynth|BLD Pharm|Chem-Space.com Database|ChemBank|ChEMBL|ChemSpider|Collaborative Drug Discovery, Inc.|Combi-Blocks|CymitQuimica|DiscoveryGate|eMolecules|EvitaChem|Google Patents|Hairui Chemical|IBM|Lan Pharmatech|LGC Standards|MolCore|MolGenie|Molport|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Sigma-Aldrich|Smolecule|Starshine Chemical|SureChEMBL|The Scripps Research Institute Molecular Screening Center|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,""
11354735,Celecoxib and erlotinib,Celecoxib and erlotinib|Celecoxib / erlotinib|Erlotinib / celecoxib|Celecoxib regimen with erlotinib|DMFYYBFUYUTKKD-UHFFFAOYSA-N|Celecoxib regimen with erlotinib hydrochloride|S900006110,774.800,C39H37F3N6O6S,161.000,1100.000,"",55,2,14,14,"InChI=1S/C22H23N3O4.C17H14F3N3O2S/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);2-10H,1H3,(H2,21,24,25)",CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F.COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,DMFYYBFUYUTKKD-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide",774.24473858,774.24473858,0,2,0,0,0,0,0,0,0,0,5,3,"",Classification|Patents,2,"",20061026,"ChemIDplus|ChemSpider|ECI Group, LCSB, University of Luxembourg|Google Patents|MolGenie|NextBio|Thomson Pharma",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
49849306,Erlotinib-13C6 Hydrochloride,"1210610-07-3|Erlotinib-13C6 Hydrochloride|Erlotinib HCl-13C6|N-(5-Ethynyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|Erlotinib-13C6 (hydrochloride)|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine-13C6 Hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline-13C6 Hydrochloride; [6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine-13C6 HydrochloridCP 358774-13C6; OSI 774-13C6; Tarceva-13C6;|DTXSID20678644|HY-12008S1|DA-52986|CS-0375162|N-(3-Ethynylphenyl-1,2,3,4,5,6-13C6)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|N-[3-Ethynyl(~13~C_6_)phenyl]-6,7-bis(2-methoxyethoxy)quinazolin-4-amine--hydrogen chloride (1/1)|N-[3-ethynyl(1,2,3,4,5,6-13C6)phenyl]-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride",435.900,C22H24ClN3O4,74.700,525.000,"",30,2,7,11,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H/i5+1,6+1,7+1,12+1,16+1,17+1;",COCCOC1=C(C=C2C(=C1)C(=NC=N2)N[13C]3=[13CH][13CH]=[13CH][13C](=[13CH]3)C#C)OCCOC.Cl,GTTBEUCJPZQMDZ-WQQMTWEQSA-N,"N-(5-ethynyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",435.1656630,435.1656630,0,2,6,0,0,0,0,0,0,0,1,1,"",Classification|Patents,2,"",20110201,"AbaChemScene|Alsachim|BenchChem|BLD Pharm|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|Clearsynth|Debye Scientific Co., Ltd|EPA DSSTox|EvitaChem|Google Patents|InvivoChem|LGC Standards|MedChemexpress MCE|MuseChem|Smolecule|TargetMol|THE BioTek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
18925039,Didesmethyl Erlotinib Hydrochloride Salt,"183320-12-9|Didesmethyl Erlotinib Hydrochloride Salt|DIDESMETHYL ERLOTINIB HCL SALT|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-hydroxyethoxy)-7-quinazolinyl]oxy]-, hydrochloride (1:1)|2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol;hydrochloride|6PK6W9S7J8|SCHEMBL1507714|DIDESMETHYLERLOTINIBHCLSALT|DTXSID50596529|BCP27884|AKOS030254417|2,2 inverted exclamation mark -[[4-[(3-Ethynylphenyl)amino]-6,7-quinazolinediyl]bis(oxy)]bis-ethanol Monohydrochloride|CS-0163972|2,2'-((4-((3-ethynylphenyl)amino)quinazoline-6,7-diyl)bis(oxy))diethanol hydrochloride? (Erlotinib Impurity pound(c)|2,2'-{[4-(3-Ethynylanilino)quinazoline-6,7-diyl]bis(oxy)}di(ethan-1-ol)--hydrogen chloride (1/1)|Ethanol, 2,2'-[[4-[(3-ethynylphenyl)amino]-6,7-quinazolinediyl]bis(oxy)]bis-, monohydrochloride|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-hydroxyethoxy)-7-quinazolinyl]oxy]-, hydrochloride",401.800,C20H20ClN3O4,96.700,497.000,"",28,4,7,9,"InChI=1S/C20H19N3O4.ClH/c1-2-14-4-3-5-15(10-14)23-20-16-11-18(26-8-6-24)19(27-9-7-25)12-17(16)21-13-22-20;/h1,3-5,10-13,24-25H,6-9H2,(H,21,22,23);1H",C#CC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OCCO)OCCO.Cl,CUXTVYBENQCZOP-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol;hydrochloride,401.1142338,401.1142338,0,2,0,0,0,0,0,0,0,0,19,3,"",Classification|Patents,2,"",20071204,"10X CHEM|1st Scientific|A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alsachim|Ambinter|Angene Chemical|AstaTech, Inc.|BenchChem|BioChemPartner|Biocore|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Clinivex|CymitQuimica|DiscoveryGate|eMolecules|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|LGC Standards|Molport|MuseChem|PATENTSCOPE (WIPO)|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Tractus|Wikidata|Yuhao Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
24825688,Erlotinib D6,"Erlotinib D6|Erlotinib-d6|1034651-23-4|N-(3-ethynylphenyl)-6,7-bis[2-(trideuteriomethoxy)ethoxy]quinazolin-4-amine|SCHEMBL13087052|HY-50896S|AKOS040733125|DA-52987|CS-0111585",399.500,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)/i2D3,3D3",[2H]C([2H])([2H])OCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC([2H])([2H])[2H],AAKJLRGGTJKAMG-XERRXZQWSA-N,"N-(3-ethynylphenyl)-6,7-bis[2-(trideuteriomethoxy)ethoxy]quinazolin-4-amine",399.20651670,399.20651670,0,1,6,0,0,0,0,0,0,0,9,5,"",Literature|Patents,2,"",20080707,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Achemtek|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambinter|AstaTech, Inc.|BenchChem|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemTik|Clearsynth|Clinivex|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|eNovation Chemicals|EvitaChem|Google Patents|Hairui Chemical|IBM|InvivoChem|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|LGC Standards|MedChemexpress MCE|Molport|MuseChem|PATENTSCOPE (WIPO)|Probes & Drugs portal|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Smolecule|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
86664461,Erlotinib trifluoroacetate,erlotinib trifluoroacetate,506.400,C24H23F3N3O6-,115.000,603.000,"",36,1,12,11,"InChI=1S/C22H23N3O4.C2HF3O2/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;3-2(4,5)1(6)7/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);(H,6,7)/p-1",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.C(=O)(C(F)(F)F)[O-],XUJFJVNCOUNOFZ-UHFFFAOYSA-M,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;2,2,2-trifluoroacetate",506.15389495,506.15389495,-1,2,0,0,0,0,0,0,0,0,2,1,"",Classification|Patents,2,"",20150202,"ECI Group, LCSB, University of Luxembourg|NextMove Software",Curation Efforts|Research and Development,""
18925062,6-O-Desmethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride,183320-04-9|6-O-Desmethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride|6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine hydrochloride|6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amineHCl|6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-4-quinazolinamine Hydrochloride (1:1);  6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride|MFCD32201947|SCHEMBL1507669|NQFZBXSVTMDWFQ-UHFFFAOYSA-N|BCP31067|F19358|6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-aminehydrochloride|N-(3-ethynylphenyl)-6(2-chloroethoxy)-7-(2-methoxyethoxy)quinazolin-4-amine hydrochloride|[6-(2-Chloro-ethoxy)-7-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine Hydrochloride|6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride,434.300,C21H21Cl2N3O3,65.500,514.000,"",29,2,6,10,"InChI=1S/C21H20ClN3O3.ClH/c1-3-15-5-4-6-16(11-15)25-21-17-12-19(27-8-7-22)20(28-10-9-26-2)13-18(17)23-14-24-21;/h1,4-6,11-14H,7-10H2,2H3,(H,23,24,25);1H",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCl.Cl,NQFZBXSVTMDWFQ-UHFFFAOYSA-N,6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine;hydrochloride,433.0959969,433.0959969,0,2,0,0,0,0,0,0,0,1,24,5,"",Literature|Patents,2,"",20071204,"001Chemical|A2B Chem|AA BLOCKS|abcr GmbH|AiFChem, an XtalPi Company|Amadis Chemical|AstaTech, Inc.|BenchChem|BioChemPartner|BLD Pharm|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|CymitQuimica|eMolecules|Google Patents|LGC Standards|Mcule|MolCore|Molport|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|RR Scientific|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,""
71315775,Desmethyl Erlotinib Carboxylate Acid,"Desmethyl Erlotinib Carboxylate Acid|882172-60-3|{[4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxy}acetic acid|1170354-84-3|Acetic acid,[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-|DTXSID60747565|3G35UZ6493|2-((4-((3-Ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)acetic acid|2-[[4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]acetic acid|Acetic acid, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-",393.400,C21H19N3O5,103.000,580.000,3.100,29,2,8,10,"InChI=1S/C21H19N3O5/c1-3-14-5-4-6-15(9-14)24-21-16-10-18(29-12-20(25)26)19(28-8-7-27-2)11-17(16)22-13-23-21/h1,4-6,9-11,13H,7-8,12H2,2H3,(H,25,26)(H,22,23,24)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCC(=O)O,KNCLPBMNMFPIIO-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyacetic acid,393.13247072,393.13247072,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20130517,A2B Chem|AA BLOCKS|Alfa Chemistry|Ambinter|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Clearsynth|CymitQuimica|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Hairui Chemical|MuseChem|PATENTSCOPE (WIPO)|RR Scientific|Smolecule|Starshine Chemical|THE BioTek|Yuhao Chemical|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
17941940,Erlotinib monohydrate,"Erlotinib monohydrate|SCHEMBL417841|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine monohydrate",411.500,C22H25N3O5,75.700,525.000,"",30,2,8,11,"InChI=1S/C22H23N3O4.H2O/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H2",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.O,BIIGENVDQCTTAU-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrate",411.17942091,411.17942091,0,2,0,0,0,0,0,0,0,1,19,5,"",Literature|Patents,2,"",20071204,ChemSpider|Crystallography Open Database (COD)|DiscoveryGate|PATENTSCOPE (WIPO)|SureChEMBL,Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
76969213,"2-(3-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid","882420-21-5|Erlotinib metabolite M6|CP-457493|2-(3-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid|OSI-493|X0JH558S7E|2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]acetic acid|Benzeneacetic acid, 3-((6,7-bis(2-methoxyethoxy)-4-quinazolinyl)amino)-|Erlotinib carboxylic acid|UNII-X0JH558S7E|AKOS040751279|Q27293202",427.400,C22H25N3O6,112.000,539.000,2.500,31,2,9,12,"InChI=1S/C22H25N3O6/c1-28-6-8-30-19-12-17-18(13-20(19)31-9-7-29-2)23-14-24-22(17)25-16-5-3-4-15(10-16)11-21(26)27/h3-5,10,12-14H,6-9,11H2,1-2H3,(H,26,27)(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)CC(=O)O)OCCOC,WYPNJRWSAMNEIY-UHFFFAOYSA-N,"2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]acetic acid",427.17433553,427.17433553,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification|Patents,2,"",20140825,"A2B Chem|AKos Consulting & Solutions|BenchChem|BLD Pharm|BOC Sciences|ChemIDplus|CymitQuimica|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|EvitaChem|FDA Global Substance Registration System (GSRS)|Hairui Chemical|InvivoChem|Mcule|MuseChem|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|TargetMol|THE BioTek|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
21991798,"6,7-Bis(2-methoxyethoxy)-4-quinazolinamine","1417161-98-8|Erlotinib impurity 24|6,7-bis(2-methoxyethoxy)-4-quinazolinamine|6,7-bis(2-methoxyethoxy)quinazolin-4-amine|4-Quinazolinamine, 6,7-bis(2-methoxyethoxy)-; 6,7-Bis(2-methoxyethoxy)-4-quinazolinamine|SCHEMBL2221126|CS-0163978|NS00133453|6,7-bis(2-methoxyethoxy)quinazolin-4-amine? (Erlotinib Impurity pound(c)",293.320,C14H19N3O4,88.700,295.000,0.800,21,1,7,8,"InChI=1S/C14H19N3O4/c1-18-3-5-20-12-7-10-11(16-9-17-14(10)15)8-13(12)21-6-4-19-2/h7-9H,3-6H2,1-2H3,(H2,15,16,17)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)N)OCCOC,FITYFYMINUEMHW-UHFFFAOYSA-N,"6,7-bis(2-methoxyethoxy)quinazolin-4-amine",293.13755610,293.13755610,0,1,0,0,0,0,0,0,0,0,40,24,"",Classification|Patents,2,"",20071205,"10X CHEM|A2B Chem|AbaChemScene|ChemSpider|CymitQuimica|Google Patents|Hairui Chemical|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LGC Standards|MolCore|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|SCRIPDB|SureChEMBL|Synthink Research Chemicals",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
18925024,4-Chloro-6-(2-chloroethoxy)-7-(2-methoxyethoxy)quinazoline,"183322-19-2|4-Chloro-6-(2-chloroethoxy)-7-(2-methoxyethoxy)quinazoline|4-CHLORO-6-(2-CHLORO-ETHOXY)-7-(2-METHOXY-ETHOXY)-QUINAZOLINE|DTXSID30596527|4-Chloro-6-(2-chloroethoxy)-7-(2-methoxyethoxy)quinazoline;|RORJMEOQKVOQBC-UHFFFAOYSA-N|2UEM9RP6JA|SCHEMBL1507495|DTXCID60547289|4-chloro-6-(2-chloroethoxy)-7-(2-methoxy-ethoxy)quinazoline|AKOS027447488|DB-262995|CS-0164639|4-chloro-6(2-chloroethoxy)-7-(2-methoxyethoxy)quinazoline|4-chloro-6-(2-chloro-ethoxy)-7-(2-methoxyethoxy)-quinazoline|Quinazoline, 4-chloro-6-(2-chloroethoxy)-7-(2-methoxyethoxy)-|4-chloro-6-(2-chloroethoxy)-7-(2-methoxyethoxy)quinazoline? (Erlotinib Impurity pound(c)",317.160,C13H14Cl2N2O3,53.500,286.000,2.900,20,0,5,7,"InChI=1S/C13H14Cl2N2O3/c1-18-4-5-20-12-7-10-9(13(15)17-8-16-10)6-11(12)19-3-2-14/h6-8H,2-5H2,1H3",COCCOC1=C(C=C2C(=C1)N=CN=C2Cl)OCCCl,RORJMEOQKVOQBC-UHFFFAOYSA-N,4-chloro-6-(2-chloroethoxy)-7-(2-methoxyethoxy)quinazoline,316.0381477,316.0381477,0,1,0,0,0,0,0,0,0,1,40,4,"",Literature|Patents,2,"",20071204,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Angene Chemical|BenchChem|Bic Biotech|BLD Pharm|BOC Sciences|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clinivex|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|LabNetwork, a WuXi AppTec Company|LGC Standards|MolCore|Molport|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|PubChem Reference Collection|RR Scientific|Santa Cruz Biotechnology, Inc.|SCRIPDB|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|THE BioTek|Tractus|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
11106619,Ethyl 4-ethoxy-3-hydroxybenzoate,Ethyl 4-ethoxy-3-hydroxybenzoate|382150-30-3|SCHEMBL1990526|DZSNTBDVMPRWQC-UHFFFAOYSA-N|DA-33886|4-Ethoxy-3-hydroxy-benzoic Acid Ethyl Ester|CS-0163939|Ethyl 4-ethoxy-3-hydroxybenzoate (Erlotinib Impurity pound(c),210.230,C11H14O4,55.800,205.000,2.100,15,1,4,5,"InChI=1S/C11H14O4/c1-3-14-10-6-5-8(7-9(10)12)11(13)15-4-2/h5-7,12H,3-4H2,1-2H3",CCOC1=C(C=C(C=C1)C(=O)OCC)O,DZSNTBDVMPRWQC-UHFFFAOYSA-N,ethyl 4-ethoxy-3-hydroxybenzoate,210.08920892,210.08920892,0,1,0,0,0,0,0,0,0,0,35,3,"",Patents|Spectral Information,2,"",20061026,"001Chemical|A&J Pharmtech CO., LTD.|AbaChemScene|Ambinter|BenchChem|Bic Biotech|BLD Pharm|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|EvitaChem|Finetech Industry Limited|Google Patents|IBM|MolCore|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|THE BioTek|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
12759146,"2,3-Dibromo-3-(3-nitrophenyl)propanoic acid","2,3-dibromo-3-(3-nitrophenyl)propanoic acid|18193-72-1|Benzenepropanoic acid, alpha,beta-dibromo-3-nitro-|starbld0020132|BBL018975|STL119780|AKOS005062872|VS-06851|CS-0163950|2,3-Dibromo-3-(3-nitrophenyl)propanoic Acid (Erlotinib Impurity pound(c)",352.960,C9H7Br2NO4,83.100,281.000,2.700,16,1,4,3,"InChI=1S/C9H7Br2NO4/c10-7(8(11)9(13)14)5-2-1-3-6(4-5)12(15)16/h1-4,7-8H,(H,13,14)",C1=CC(=CC(=C1)[N+](=O)[O-])C(C(C(=O)O)Br)Br,AYUJMWVMPDGXFF-UHFFFAOYSA-N,"2,3-dibromo-3-(3-nitrophenyl)propanoic acid",352.87213,350.87418,0,1,0,2,0,2,0,0,0,1,1,1,"",Literature|Patents,2,"",20070208,"A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Ambinter|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|DiscoveryGate|Google Patents|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|Mcule|Molport|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SynHet - Synthetic Heterocycles|Thieme Chemistry|Vitas-M Laboratory",Chemical Vendors|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
16045656,2-[4-(3-Ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol,"183321-84-8|4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline|Erlotinib metabolite M12|2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol|CP-373943|OSI-943|2,2'-((4-((3-ethynylphenyl)amino)quinazoline-6,7-diyl)bis(oxy))diethanol|92T0F45VE1|Ethanol, 2,2'-[[4-[(3-ethynylphenyl)amino]-6,7-quinazolinediyl]bis(oxy)]bis-|2-(4-(3-Ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl)oxyethanol|Ethanol, 2,2'-((4-((3-ethynylphenyl)amino)-6,7-quinazolinediyl)bis(oxy))bis-|Ethanol, 2-((4-((3-ethynylphenyl)amino)-6-(2-hydroxyethoxy)-7-quinazolinyl)oxy)-|2-({4-[(3-ethynylphenyl)amino]-6-(2-hydroxyethoxy)quinazolin-7-yl}oxy)ethan-1-ol|UNII-92T0F45VE1|SCHEMBL1507594|DTXSID40581464|AKOS015907687|Q27271527|2,2'-{[4-(3-Ethynylanilino)quinazoline-6,7-diyl]bis(oxy)}di(ethan-1-ol)",365.400,C20H19N3O4,96.700,497.000,2.200,27,3,7,9,"InChI=1S/C20H19N3O4/c1-2-14-4-3-5-15(10-14)23-20-16-11-18(26-8-6-24)19(27-9-7-25)12-17(16)21-13-22-20/h1,3-5,10-13,24-25H,6-9H2,(H,21,22,23)",C#CC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OCCO)OCCO,YWSAEKIQJPQSDJ-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol,365.13755610,365.13755610,0,1,0,0,0,0,0,0,0,0,67,14,"",Classification|Patents,2,"",20070430,"001Chemical|10X CHEM|1st Scientific|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|Acorn PharmaTech Product List|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Apexmol|AstaTech, Inc.|BenchChem|Bic Biotech|BioChemPartner|Biocore|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Clinivex|CymitQuimica|Day Biochem|DiscoveryGate|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|eMolecules|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|ISpharm|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|LGC Standards|MolCore|Molport|MuseChem|PATENTSCOPE (WIPO)|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Tractus|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
46781490,Erlotinib D6 HCl,"Erlotinib D6 HCl|1189953-78-3|Erlotinib-d6 Hydrochloride|Erlotinib-d6 (hydrochloride)|N-(3-ethynylphenyl)-6,7-bis[2-(trideuteriomethoxy)ethoxy]quinazolin-4-amine;hydrochloride|Erlotinib D6 Hydrochloride|Tarceva-d3|Erlotinib-d6, Hydrochloride Salt|N-(3-Ethynylphenyl)-6,7-bis[2-(trideuteriomethoxy)ethoxy]quinazolin-4-amine hydrochloride; N-(3-Ethynylphenyl)-6,7-bis[2-(methoxy-d3)ethoxy]-4-quinazolinamine hydrochloride; Erlotinib-d6 hydrochloride; Erlotinib-D6 hydrochloride (bis(methoxy-D3))|ERLOTINIB-D6 HCL|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy-d3)-4-quinazolinamine Hydrochloride|SCHEMBL3057695|1ST162381AD6|HY-12008S|AKOS040744236|DA-63270|MS-27811|CS-0019809|G13617",435.900,C22H24ClN3O4,74.700,525.000,"",30,2,7,11,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H/i2D3,3D3;",[2H]C([2H])([2H])OCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC([2H])([2H])[2H].Cl,GTTBEUCJPZQMDZ-HVTBMTIBSA-N,"N-(3-ethynylphenyl)-6,7-bis[2-(trideuteriomethoxy)ethoxy]quinazolin-4-amine;hydrochloride",435.1831944,435.1831944,0,2,6,0,0,0,0,0,0,0,1,1,"",Patents,1,"",20100726,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Achemtek|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambinter|AstaTech, Inc.|BenchChem|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemTik|Clearsynth|Clinivex|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|eNovation Chemicals|Hairui Chemical|InvivoChem|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|LGC Standards|MedChemexpress MCE|Molport|MuseChem|Probes & Drugs portal|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|SureChEMBL|TargetMol|THE BioTek",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,""
9913428,Erlotinib mesylate,"ERLOTINIB MESYLATE|248594-19-6|Erlotinib (mesylate)|248594-19-6 (mesylaye)|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;methanesulfonic acid|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine  methansulfonic acid|ERLOTINIBMESYLATE|SCHEMBL33835|Erlotinib, Methanesulfonate Salt|PCBNMUVSOAYYIH-UHFFFAOYSA-N|HY-12008A|AKOS030526750|CS-1586|FE65018|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine methanesulfonate|DA-52985|n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate salt",489.500,C23H27N3O7S,137.000,618.000,"",34,2,10,11,"InChI=1S/C22H23N3O4.CH4O3S/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;1-5(2,3)4/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H3,(H,2,3,4)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.CS(=O)(=O)O,PCBNMUVSOAYYIH-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;methanesulfonic acid",489.15697138,489.15697138,0,2,0,0,0,0,0,0,0,0,317,79,"",Patents,1,"",20061025,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|Adooq BioScience|AKos Consulting & Solutions|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|BenchChem|Bic Biotech|BioCrick|Biosynth|BLD Pharm|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|Cooke Chemical Co., Ltd|CSNpharm|CymitQuimica|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Finetech Industry Limited|Google Patents|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Mcule|MedChemexpress MCE|Molport|MuseChem|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Pi Chemicals|Probes & Drugs portal|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|TargetMol|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
16045654,Erlotinib iMpurity B,"Erlotinib iMpurity B|183321-83-7|6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine|6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-4-quinazolinamine|4-Quinazolinamine, 6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-|ErlotinibiMpurityB|D64THV2KES|SCHEMBL1507587|Erlotinib iMpurity, 6-(2-Methoxyethoxy)-7-(2-chloroethoxy)|BCP28108|CS-Z0002|AS-79679|C12550",397.900,C21H20ClN3O3,65.500,514.000,4.000,28,1,6,10,"InChI=1S/C21H20ClN3O3/c1-3-15-5-4-6-16(11-15)25-21-17-12-19(27-8-7-22)20(28-10-9-26-2)13-18(17)23-14-24-21/h1,4-6,11-14H,7-10H2,2H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCl,DBLVDARHJKFUSK-UHFFFAOYSA-N,6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine,397.1193192,397.1193192,0,1,0,0,0,0,0,0,0,0,73,17,"",Patents,1,"",20070430,"001Chemical|10X CHEM|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Accel Scientific|Achemtek|Acmec Biochemical|AiFChem, an XtalPi Company|Amadis Chemical|Ambinter|AppChem|AstaTech, Inc.|BenchChem|BioChemPartner|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|CymitQuimica|DiscoveryGate|eMolecules|eNovation Chemicals|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|LGC Standards|Mcule|MolCore|Molport|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|RR Scientific|SCRIPDB|Smolecule|Springer Nature|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Synthonix, Inc.|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
16045729,Erlotinib Acetate,"Erlotinib Acetate|183320-24-3|SCHEMBL1507474|TZHTWWZUWBDHPB-UHFFFAOYSA-N|7-(2-Acetoxy-ethoxy)-4-(3-ethynyl-phenylamino)-6-(2-methoxy-ethoxy)-quinazoline|Erlotinib Acetate; Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-, 1-acetate; Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-, acetate (ester) (9CI); 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quin",421.400,C23H23N3O5,91.800,609.000,3.300,31,1,8,12,"InChI=1S/C23H23N3O5/c1-4-17-6-5-7-18(12-17)26-23-19-13-21(30-9-8-28-3)22(14-20(19)24-15-25-23)31-11-10-29-16(2)27/h1,5-7,12-15H,8-11H2,2-3H3,(H,24,25,26)",CC(=O)OCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCOC,TZHTWWZUWBDHPB-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethyl acetate,421.16377084,421.16377084,0,1,0,0,0,0,0,0,0,0,71,14,"",Patents,1,"",20070430,BOC Sciences|ChemSpider|DiscoveryGate|Google Patents|IBM|LGC Standards|NextMove Software|PATENTSCOPE (WIPO)|SLING Consortium|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
16045728,Erlotinib impurity A,"Erlotinib impurity A|183321-85-9|4-QuinazolinaMine, 7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-Methoxyethoxy)-|7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine|ErlotinibimpurityA|SCHEMBL1507484|CS-Z0003|7-(2-Chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)-4-quinazolinamine|AS-79680|C12549",397.900,C21H20ClN3O3,65.500,514.000,4.000,28,1,6,10,"InChI=1S/C21H20ClN3O3/c1-3-15-5-4-6-16(11-15)25-21-17-12-19(28-10-9-26-2)20(27-8-7-22)13-18(17)23-14-24-21/h1,4-6,11-14H,7-10H2,2H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCCl,BIHHIONDWPZXJC-UHFFFAOYSA-N,7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine,397.1193192,397.1193192,0,1,0,0,0,0,0,0,0,0,61,14,"",Patents,1,"",20070430,"001Chemical|10X CHEM|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Accel Scientific|Achemtek|Acmec Biochemical|Ambinter|AppChem|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|CymitQuimica|DiscoveryGate|eMolecules|eNovation Chemicals|EvitaChem|Google Patents|Hairui Chemical|IBM|J&H Chemical Co.,ltd|Key Organics/BIONET|LGC Standards|Mcule|MolCore|Molport|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|SynHet - Synthetic Heterocycles|Synthonix, Inc.|THE BioTek|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
139060835,Erlotinib fumaric acid hemisolvate dihydrate,"Erlotinib fumaric acid hemisolvate dihydrate|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine fumaric acid hemisolvate dihydrate",975.000,C48H58N6O16,228.000,644.000,"",70,8,22,24,"InChI=1S/2C22H23N3O4.C4H4O4.4H2O/c2*1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;5-3(6)1-2-4(7)8;;;;/h2*1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1-2H,(H,5,6)(H,7,8);4*1H2/b;;2-1+;;;;",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.C(=C/C(=O)O)\C(=O)O.O.O.O.O,HDFYEVNKDZAAQJ-OGLYGEJJSA-N,"(E)-but-2-enedioic acid;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;tetrahydrate",974.39092978,974.39092978,0,7,0,0,0,0,1,1,0,1,0,0,"",Literature,1,"",20191003,Crystallography Open Database (COD),Research and Development,""
156596548,Erlotinib metabolite M17,"Erlotinib metabolite M17|8XM9WDB2RD|UNII-8XM9WDB2RD|2-Ethynyl-4-((6-(2-hydroxyethoxy)-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenol|Phenol, 2-ethynyl-4-((6-(2-hydroxyethoxy)-7-(2-methoxyethoxy)-4-quinazolinyl)amino)-|882172-55-6",395.400,C21H21N3O5,106.000,542.000,2.400,29,3,8,10,"InChI=1S/C21H21N3O5/c1-3-14-10-15(4-5-18(14)26)24-21-16-11-19(28-7-6-25)20(29-9-8-27-2)12-17(16)22-13-23-21/h1,4-5,10-13,25-26H,6-9H2,2H3,(H,22,23,24)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)O)C#C)OCCO,KTVMWNNTYIAZAL-UHFFFAOYSA-N,2-ethynyl-4-[[6-(2-hydroxyethoxy)-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenol,395.14812078,395.14812078,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20210916,ChemIDplus|FDA Global Substance Registration System (GSRS)|Starshine Chemical,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
16045727,Desmethyl Erlotinib Acetate,"Desmethyl Erlotinib Acetate|183320-15-2|2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethyl acetate|Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-, 1-acetate|6-(2-Acetoxy-ethoxy)-4-(3-ethynyl-phenylamino)-7-(2-methoxy-ethoxy)quinazoline; 2-[[4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]ethanol 1-Acetate; 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]|DesmethylErlotinibAcetate|SCHEMBL1507567|DTXSID20581467|XSMVZQAPXNUGBP-UHFFFAOYSA-N|AKOS030255395|NCGC00189235-01|2-{[4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxy}ethyl acetate|6-(2-Acetoxy-ethoxy)-4-(3-ethynyl-phenylamino)-7-(2-methoxy-ethoxy)-quinazoline",421.400,C23H23N3O5,91.800,609.000,3.300,31,1,8,12,"InChI=1S/C23H23N3O5/c1-4-17-6-5-7-18(12-17)26-23-19-13-21(31-11-10-29-16(2)27)22(30-9-8-28-3)14-20(19)24-15-25-23/h1,5-7,12-15H,8-11H2,2-3H3,(H,24,25,26)",CC(=O)OCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,XSMVZQAPXNUGBP-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethyl acetate,421.16377084,421.16377084,0,1,0,0,0,0,0,0,0,0,77,16,"",Patents,1,"",20070430,"1st Scientific|A2B Chem|AA BLOCKS|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Angene Chemical|AstaTech, Inc.|BenchChem|Biocore|BLD Pharm|BOC Sciences|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Clinivex|CymitQuimica|DiscoveryGate|eMolecules|EPA DSSTox|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|LGC Standards|Molport|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMove Software|PATENTSCOPE (WIPO)|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thomson Pharma|Tractus|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,""
86640910,Erlotinib sulphate,erlotinib sulphate|MZDJBVMIYMTMQX-UHFFFAOYSA-L,489.500,C22H23N3O8S-2,163.000,588.000,"",34,1,11,11,"InChI=1S/C22H23N3O4.H2O4S/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;1-5(2,3)4/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);(H2,1,2,3,4)/p-2",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.[O-]S(=O)(=O)[O-],MZDJBVMIYMTMQX-UHFFFAOYSA-L,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;sulfate",489.12058587,489.12058587,-2,2,0,0,0,0,0,0,0,0,3,1,"",Patents,1,"",20150202,NextMove Software,Curation Efforts|Research and Development,""
144469368,7-(2-Hydroxyethoxy)-6-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),CS-0163945|7-(2-Hydroxyethoxy)-6-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),280.280,C13H16N2O5,89.400,350.000,-0.200,20,2,6,7,"InChI=1S/C13H16N2O5/c1-18-4-5-20-11-6-9-10(14-8-15-13(9)17)7-12(11)19-3-2-16/h6-8,16H,2-5H2,1H3,(H,14,15,17)",COCCOC1=C(C=C2C(=C1)C(=O)NC=N2)OCCO,GFAXKQHQUZDEPZ-UHFFFAOYSA-N,7-(2-hydroxyethoxy)-6-(2-methoxyethoxy)-3H-quinazolin-4-one,280.10592162,280.10592162,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20191207,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
154575122,Ethyl 5-hydroxy-4-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),CS-0163922|Ethyl 5-hydroxy-4-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),285.250,C12H15NO7,111.000,330.000,1.400,20,1,7,7,"InChI=1S/C12H15NO7/c1-3-19-12(15)8-6-10(14)11(20-5-4-18-2)7-9(8)13(16)17/h6-7,14H,3-5H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1[N+](=O)[O-])OCCOC)O,NPEDNOOUVHVIKH-UHFFFAOYSA-N,ethyl 5-hydroxy-4-(2-methoxyethoxy)-2-nitrobenzoate,285.08485182,285.08485182,0,1,0,0,0,0,0,0,0,0,1,1,"",Patents,1,"",20200904,AbaChemScene|Google Patents|Lan Pharmatech,Chemical Vendors|Legacy Depositors|Research and Development,""
156596489,Erlotinib metabolite M2,"Erlotinib metabolite M2|JBW9REG8TL|UNII-JBW9REG8TL|2-(3-((6-(2-Hydroxyethoxy)-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)acetic acid|Benzeneacetic acid, 3-((7-(2-hydroxyethoxy)-6-(2-methoxyethoxy)-4-quinazolinyl)amino)-|882172-52-3",413.400,C21H23N3O6,123.000,525.000,2.000,30,3,9,11,"InChI=1S/C21H23N3O6/c1-28-7-8-30-19-12-17-16(11-18(19)29-6-5-25)21(23-13-22-17)24-15-4-2-3-14(9-15)10-20(26)27/h2-4,9,11-13,25H,5-8,10H2,1H3,(H,26,27)(H,22,23,24)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)CC(=O)O)OCCO,IILOHZUILAOXFW-UHFFFAOYSA-N,2-[3-[[6-(2-hydroxyethoxy)-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]acetic acid,413.15868546,413.15868546,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20210916,ChemIDplus|FDA Global Substance Registration System (GSRS)|Starshine Chemical,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
59336201,N-(2-Methoxyethyl) Erlotinib,N-(2-Methoxyethyl) Erlotinib|SCHEMBL13320760,451.500,C25H29N3O5,75.200,600.000,3.300,33,0,8,14,"InChI=1S/C25H29N3O5/c1-5-19-7-6-8-20(15-19)28(9-10-29-2)25-21-16-23(32-13-11-30-3)24(33-14-12-31-4)17-22(21)26-18-27-25/h1,6-8,15-18H,9-14H2,2-4H3",COCCN(C1=CC=CC(=C1)C#C)C2=NC=NC3=CC(=C(C=C32)OCCOC)OCCOC,LQXXAMRRMMNQRX-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-N-(2-methoxyethyl)quinazolin-4-amine",451.21072103,451.21072103,0,1,0,0,0,0,0,0,0,0,2,1,"",Patents,1,"",20120820,Google Patents|IBM|LGC Standards|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
86640911,Erlotinib tosylate,erlotinib tosylate|XUPNDGCKDFRETL-UHFFFAOYSA-M,564.600,C29H30N3O7S-,140.000,718.000,"",40,1,10,11,"InChI=1S/C22H23N3O4.C7H8O3S/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;1-6-2-4-7(5-3-6)11(8,9)10/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);2-5H,1H3,(H,8,9,10)/p-1",CC1=CC=C(C=C1)S(=O)(=O)[O-].COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,XUPNDGCKDFRETL-UHFFFAOYSA-M,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;4-methylbenzenesulfonate",564.18044648,564.18044648,-1,2,0,0,0,0,0,0,0,0,3,1,"",Patents,1,"",20150202,NextMove Software,Curation Efforts|Research and Development,""
16045653,"6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine","Erlotinib iMpurity|183321-82-6|6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine|Erlotinib impurity, 6,7-bis(2-chloroethoxy)|EVS3LP8NDM|SCHEMBL1507548|BCP09866|CS-0164000|6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)-4-quinazolinamine|4-Quinazolinamine, 6,7-bis(2-chloroethoxy)-N-(3-ethynylphenyl)-|6,7-bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine? (Erlotinib Impurity pound(c)|Erlotinib impurity 6; Ethyl 4,5-Bis(2-methoxy ethoxy)-2-nitrobenzoate;6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)-4-quinazolinamine",402.300,C20H17Cl2N3O2,56.300,501.000,4.800,27,1,5,9,"InChI=1S/C20H17Cl2N3O2/c1-2-14-4-3-5-15(10-14)25-20-16-11-18(26-8-6-21)19(27-9-7-22)12-17(16)23-13-24-20/h1,3-5,10-13H,6-9H2,(H,23,24,25)",C#CC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OCCCl)OCCCl,OPZQXOBOVGSGMM-UHFFFAOYSA-N,"6,7-bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine",401.0697822,401.0697822,0,1,0,0,0,0,0,0,0,0,66,16,"",Patents,1,"",20070430,"A2B Chem|A2Z Chemical|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|Alfa Chemistry|Ambinter|BenchChem|BioChemPartner|Biocore|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Clinivex|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|LGC Standards|Mcule|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thomson Pharma|Tractus|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
18925012,2-[4-(3-Ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol;hydrochloride,"183365-34-6|2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol;hydrochloride|7-(2-Desmethyl) erlotinib|SCHEMBL1507491|BCP29717|IHA36534|7-(2 inverted exclamation mark -Desmethyl) Erlotinib|7-(2'-Desmethyl) Erlotinib; Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-, hydrochloride (1:1); Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-, monohydrochloride (9CI); 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyet|OSI-413 pound>>2-[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-ethanol Hydrochloride",415.900,C21H22ClN3O4,85.700,511.000,"",29,3,7,10,"InChI=1S/C21H21N3O4.ClH/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(28-10-9-26-2)20(27-8-7-25)13-18(17)22-14-23-21;/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCO.Cl,DIPPSATVOCYFSS-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol;hydrochloride,415.1298839,415.1298839,0,2,0,0,0,0,0,0,0,0,17,2,"",Patents,1,"",20071204,"Achemtek|Acorn PharmaTech Product List|Ambinter|BenchChem|Bic Biotech|BioChemPartner|Biosynth|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|CymitQuimica|EvitaChem|Google Patents|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LGC Standards|MuseChem|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Probes & Drugs portal|RR Scientific|Smolecule|SureChEMBL|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
122173861,"Acetic acid, ((4-((3-ethynylphenyl)amino)-6-(2-methoxyethoxy)-7-quinazolinyl)oxy)-","Erlotinib metabolite M11|NE98M1L9HG|UNII-NE98M1L9HG|Acetic acid, ((4-((3-ethynylphenyl)amino)-6-(2-methoxyethoxy)-7-quinazolinyl)oxy)-|Acetic acid, 2-((4-((3-ethynylphenyl)amino)-6-(2-methoxyethoxy)-7-quinazolinyl)oxy)-|Q27887994|Desmethyl Erlotinib Carboxylate Acid; Acetic acid, 2-[[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]-; Acetic acid, [[4-[(3-ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]- (9CI); 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]acetic ac",393.400,C21H19N3O5,103.000,580.000,3.100,29,2,8,10,"InChI=1S/C21H19N3O5/c1-3-14-5-4-6-15(9-14)24-21-16-10-18(28-8-7-27-2)19(29-12-20(25)26)11-17(16)22-13-23-21/h1,4-6,9-11,13H,7-8,12H2,2H3,(H,25,26)(H,22,23,24)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCC(=O)O,UFKZQJKDHRJVEF-UHFFFAOYSA-N,2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyacetic acid,393.13247072,393.13247072,0,1,0,0,0,0,0,0,0,0,0,0,"",Classification,1,"",20161016,"ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Egon Willighagen, Department of Bioinformatics - BiGCaT, Maastricht University|FDA Global Substance Registration System (GSRS)|LGC Standards|Starshine Chemical|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
90353082,"2-Amino-4,5-bis(2-methoxyethoxy)benzamide","236750-62-2|2-Amino-4,5-bis(2-methoxyethoxy)benzamide|4,5-Bis(2-Methoxyethoxy)anthranilamide|Erlotinib impurity 19|MA4SGX638M|SCHEMBL15966727|2-Amino-3,4-bis(2-methoxyethoxy)benzamide|CS-0164466|Benzamide, 2-amino-4,5-bis(2-methoxyethoxy)-|F19336|2-amino-4,5-bis(2-methoxyethoxy)benzamide? (Erlotinib Impurity pound(c)",284.310,C13H20N2O5,106.000,290.000,0.300,20,2,6,9,"InChI=1S/C13H20N2O5/c1-17-3-5-19-11-7-9(13(15)16)10(14)8-12(11)20-6-4-18-2/h7-8H,3-6,14H2,1-2H3,(H2,15,16)",COCCOC1=C(C=C(C(=C1)C(=O)N)N)OCCOC,PDQRGRVHDBXSSK-UHFFFAOYSA-N,"2-amino-4,5-bis(2-methoxyethoxy)benzamide",284.13722174,284.13722174,0,1,0,0,0,0,0,0,0,0,10,7,"",Patents,1,"",20150213,"A2B Chem|AA BLOCKS|AbaChemScene|Alichem|AstaTech, Inc.|BenchChem|BLD Pharm|BOC Sciences|CymitQuimica|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|Japan Chemical Substance Dictionary (Nikkaji)|LGC Standards|MolCore|Molport|PATENTSCOPE (WIPO)|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
163197328,N-(3-ethynylphenyl)-6-methoxy-7-(2-methoxyethoxy)quinazolin-4-amine,SCHEMBL24535454|CS-0163984|N-(3-ethynylphenyl)-6-methoxy-7-(2-methoxyethoxy)quinazolin-4-amine? (Erlotinib Impurity pound(c),349.400,C20H19N3O3,65.500,480.000,3.500,26,1,6,8,"InChI=1S/C20H19N3O3/c1-4-14-6-5-7-15(10-14)23-20-16-11-18(25-3)19(26-9-8-24-2)12-17(16)21-13-22-20/h1,5-7,10-13H,8-9H2,2-3H3,(H,21,22,23)",COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OC,LZRHFJUQUMOIOL-UHFFFAOYSA-N,N-(3-ethynylphenyl)-6-methoxy-7-(2-methoxyethoxy)quinazolin-4-amine,349.14264148,349.14264148,0,1,0,0,0,0,0,0,0,0,2,2,"",Patents,1,"",20220430,AbaChemScene|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,""
18925091,4-Chloro-7-(2-chloroethoxy)-6-(2-methoxyethoxy)quinazoline,"183322-20-5|4-Chloro-7-(2-chloroethoxy)-6-(2-methoxyethoxy)quinazoline|4-CHLORO-7-(2-CHLORO-ETHOXY)-6-(2-METHOXY-ETHOXY)-QUINAZOLINE|Quinazoline, 4-chloro-7-(2-chloroethoxy)-6-(2-methoxyethoxy)-|HFGVHQGBDDTDIJ-UHFFFAOYSA-N|2MP399XR6S|SCHEMBL1507551|DTXSID60596535|4-chloro-7-(2-chloroethoxy)-6-(2-methoxy-ethoxy)quinazoline|AKOS027447489|DB-263000|CS-0163936|4-Chloro-7-(2-chloroethoxy)-6-(2-methoxyethoxy)quinazoline (Erlotinib Impurity pound(c)",317.160,C13H14Cl2N2O3,53.500,286.000,2.900,20,0,5,7,"InChI=1S/C13H14Cl2N2O3/c1-18-4-5-20-11-6-9-10(16-8-17-13(9)15)7-12(11)19-3-2-14/h6-8H,2-5H2,1H3",COCCOC1=C(C=C2C(=C1)C(=NC=N2)Cl)OCCCl,HFGVHQGBDDTDIJ-UHFFFAOYSA-N,4-chloro-7-(2-chloroethoxy)-6-(2-methoxyethoxy)quinazoline,316.0381477,316.0381477,0,1,0,0,0,0,0,0,0,0,38,3,"",Patents,1,"",20071204,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Angene Chemical|BenchChem|Bic Biotech|Biocore|BLD Pharm|BOC Sciences|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Clinivex|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|EPA DSSTox|FDA Global Substance Registration System (GSRS)|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|LGC Standards|MolCore|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|SureChEMBL|THE BioTek|Tractus|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
23725558,"N'-[2-cyano-4,5-bis(2-methoxyethoxy)phenyl]-N,N-dimethylmethanimidamide","950596-59-5|N'-[2-cyano-4,5-bis(2-methoxyethoxy)phenyl]-N,N-dimethylmethanimidamide|METHANIMIDAMIDE, N'-[2-CYANO-4,5-BIS(2-METHOXYETHOXY)PHENYL]-N,N-DIMETHYL-|(E)-N'-(2-cyano-4,5-bis(2-methoxyethoxy)phenyl)-N,N-dimethylformimidamide|Erlotinib Impurity 11|8RMJ4X4AXG|SCHEMBL482255|SCHEMBL482256|SCHEMBL14345814|DTXSID10635827|N'-(2-cyano-4,5-bis(2-methoxyethoxy)phenyl)-N,N-dimethylformimidamide",321.370,C16H23N3O4,76.300,394.000,0.900,23,0,6,10,"InChI=1S/C16H23N3O4/c1-19(2)12-18-14-10-16(23-8-6-21-4)15(9-13(14)11-17)22-7-5-20-3/h9-10,12H,5-8H2,1-4H3",CN(C)C=NC1=CC(=C(C=C1C#N)OCCOC)OCCOC,DAJSDPMXDPYMCB-UHFFFAOYSA-N,"N'-[2-cyano-4,5-bis(2-methoxyethoxy)phenyl]-N,N-dimethylmethanimidamide",321.16885622,321.16885622,0,1,0,0,0,0,0,0,0,0,26,7,"",Patents,1,"",20080211,A2B Chem|AA BLOCKS|BenchChem|BLD Pharm|BOC Sciences|ChemTik|CymitQuimica|DiscoveryGate|EPA DSSTox|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|IBM|MolCore|PATENTSCOPE (WIPO)|RR Scientific|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek|Thomson Pharma|Wikidata,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
87677034,"N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine","CS-0163954|N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|N-(2-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine (Erlotinib Impurity pound(c)",393.400,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-7-5-6-8-18(16)25-22-17-13-20(28-11-9-26-2)21(29-12-10-27-3)14-19(17)23-15-24-22/h1,5-8,13-15H,9-12H2,2-3H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC=C3C#C)OCCOC,JFFVYVBOCQVNPN-UHFFFAOYSA-N,"N-(2-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",393.16885622,393.16885622,0,1,0,0,0,0,0,0,0,0,1,1,"",Patents,1,"",20150212,AbaChemScene|IBM|LGC Standards|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
152251430,2-[4-Chloro-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol,CS-0163980|2-((4-chloro-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethanol? (Erlotinib Impurity pound(c),298.720,C13H15ClN2O4,73.700,285.000,1.600,20,1,6,7,"InChI=1S/C13H15ClN2O4/c1-18-4-5-20-11-6-9-10(15-8-16-13(9)14)7-12(11)19-3-2-17/h6-8,17H,2-5H2,1H3",COCCOC1=C(C=C2C(=C1)C(=NC=N2)Cl)OCCO,WFKQSVQQJNVBES-UHFFFAOYSA-N,2-[4-chloro-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol,298.0720347,298.0720347,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20200813,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
16648286,"Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate","20825-87-0|ethyl 2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate|ethyl 2,3-dihydro-1,4-benzodioxine-6-carboxylate|1,4-Benzodioxin-6-carboxylic acid, 2,3-dihydro-, ethyl ester|MFCD06204332|2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid ethyl ester|Ethyl2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate|SCHEMBL1464834|DTXSID70586482|LIQWCKWRILLHAQ-UHFFFAOYSA-N|AKOS003063688|SY308725|CS-0163918|Z54848447|2,3-dihydro-benzo[1,4]dioxin-6-carboxylic acid ethyl ester|Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate (Erlotinib Impurity pound(c)",208.210,C11H12O4,44.800,229.000,1.000,15,0,4,3,"InChI=1S/C11H12O4/c1-2-13-11(12)8-3-4-9-10(7-8)15-6-5-14-9/h3-4,7H,2,5-6H2,1H3",CCOC(=O)C1=CC2=C(C=C1)OCCO2,LIQWCKWRILLHAQ-UHFFFAOYSA-N,"ethyl 2,3-dihydro-1,4-benzodioxine-6-carboxylate",208.07355886,208.07355886,0,1,0,0,0,0,0,0,0,0,217,16,"",Patents,1,"",20070731,"001Chemical|10X CHEM|1st Scientific|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Accela ChemBio Inc.|Achemtek|Activate Scientific|AiFChem, an XtalPi Company|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Anward|AppChem|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BerrChemical|Bic Biotech|Biocore|BLD Pharm|BOC Sciences|Chembase.cn|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|CymitQuimica|DiscoveryGate|eMolecules|Enamine|Ennopharm|eNovation Chemicals|EPA DSSTox|Founder Pharma|Google Patents|Hairui Chemical|Heterocyclics Research Chemicals & Building blocks|IBM|ISpharm|J&H Chemical Co.,ltd|Mcule|MicroCombiChem GmbH|MolCore|Molecule Market|NextMove Software|Oakwood Products|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Rare Chemicals GmbH, Germany|Rieke Metals, LLC|RR Scientific|SCRIPDB|Sigma-Aldrich|Smolecule|Starshine Chemical|SureChEMBL|Syntree|THE BioTek|Thoreauchem|Tractus|Wikidata|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
18925038,"4-Chloro-6,7-bis-(2-chloroethoxy)quinazoline","183322-21-6|4-Chloro-6,7-bis-(2-chloroethoxy)quinazoline|4-chloro-6,7-bis(2-chloroethoxy)Quinazoline|SCHEMBL1507564|DTXSID90596528|WXAZLCUYDRYLFC-UHFFFAOYSA-N|AKOS027447490|DB-065439|CS-0163970|F19357|4-Chloro-6,7-bis-(2-chloro-ethoxy)-quinazoline|4-chloro-6,7-bis(2-chloroethoxy)quinazoline? (Erlotinib Impurity pound(c)",321.600,C12H11Cl3N2O2,44.200,273.000,3.600,19,0,4,6,"InChI=1S/C12H11Cl3N2O2/c13-1-3-18-10-5-8-9(16-7-17-12(8)15)6-11(10)19-4-2-14/h5-7H,1-4H2",C1=C2C(=CC(=C1OCCCl)OCCCl)N=CN=C2Cl,WXAZLCUYDRYLFC-UHFFFAOYSA-N,"4-chloro-6,7-bis(2-chloroethoxy)quinazoline",319.988611,319.988611,0,1,0,0,0,0,0,0,0,0,36,3,"",Patents,1,"",20071204,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|Acadechem|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Angene Chemical|AstaTech, Inc.|BenchChem|Bic Biotech|Biocore|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clinivex|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|EPA DSSTox|Finetech Industry Limited|Google Patents|Hairui Chemical|IBM|J&H Chemical Co.,ltd|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|LGC Standards|MolCore|Molport|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|RR Scientific|Santa Cruz Biotechnology, Inc.|Smolecule|SureChEMBL|THE BioTek|Tractus|Wikidata|Wubei-Biochem|Yuhao Chemical|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
13430078,Ethyl 3-ethoxy-4-hydroxybenzoate,"ethyl 3-ethoxy-4-hydroxybenzoate|174674-93-2|Benzoic acid, 3-ethoxy-4-hydroxy-, ethyl ester (9CI)|SCHEMBL7715844|CS-0163938|Ethyl 3-ethoxy-4-hydroxybenzoate (Erlotinib Impurity pound(c)",210.230,C11H14O4,55.800,205.000,2.500,15,1,4,5,"InChI=1S/C11H14O4/c1-3-14-10-7-8(5-6-9(10)12)11(13)15-4-2/h5-7,12H,3-4H2,1-2H3",CCOC1=C(C=CC(=C1)C(=O)OCC)O,CTLKYWZZGQXLRT-UHFFFAOYSA-N,ethyl 3-ethoxy-4-hydroxybenzoate,210.08920892,210.08920892,0,1,0,0,0,0,0,0,0,0,7,4,"",Patents,1,"",20070208,"AbaChemScene|AiFChem, an XtalPi Company|Ambinter|Aurora Fine Chemicals LLC|BenchChem|Bic Biotech|BLD Pharm|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EvitaChem|Google Patents|IBM|MuseChem|PATENTSCOPE (WIPO)|Rare Chemicals GmbH, Germany|Smolecule|SureChEMBL|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,""
11959871,"6,7-Bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine","1058132-82-3|6,7-Bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine|N-(3-Ethenylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|Erlotinib-3-vinyl|F8Q77LUQ3Z|SCHEMBL17343566|4-Quinazolinamine, N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-",395.500,C22H25N3O4,74.700,481.000,3.800,29,1,7,11,"InChI=1S/C22H25N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h4-7,12-15H,1,8-11H2,2-3H3,(H,23,24,25)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C=C)OCCOC,LEGOGGMGARYNEO-UHFFFAOYSA-N,"N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",395.18450629,395.18450629,0,1,0,0,0,0,0,0,0,0,12,8,"",Patents,1,"",20061211,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|Alichem|Amadis Chemical|Ambeed|Angel Pharmatech Ltd.|AstaTech, Inc.|BenchChem|BePharm Ltd.|Biosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|Combi-Blocks|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|eMolecules|EvitaChem|FDA Global Substance Registration System (GSRS)|Google Patents|Hairui Chemical|IBM|LGC Standards|MolCore|Molecule Market|Molport|MuseChem|NextBio|OXCHEM CORPORATION|Smolecule|SureChEMBL|THE BioTek|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
127263954,"N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride","N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|2055841-66-0|CS-0163981|V10173|N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-aminehydrochloride|N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride? (Erlotinib Impurity pound(c)",433.900,C22H28ClN3O4,74.700,456.000,"",30,2,7,11,"InChI=1S/C22H27N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h5-7,12-15H,4,8-11H2,1-3H3,(H,23,24,25);1H",CCC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OCCOC)OCCOC.Cl,HBPDFKMRTVHBJP-UHFFFAOYSA-N,"N-(3-ethylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",433.1768341,433.1768341,0,2,0,0,0,0,0,0,0,0,1,1,"",Patents,1,"",20170618,"AbaChemScene|AiFChem, an XtalPi Company|AstaTech, Inc.|BLD Pharm|Combi-Blocks|EvitaChem|Google Patents|Molport|PATENTSCOPE (WIPO)|Sigma-Aldrich|Starshine Chemical",Chemical Vendors|Governmental Organizations|Research and Development,""
59772833,Ethyl 3-hydroxy-4-(2-methoxyethoxy)benzoate,ethyl 3-hydroxy-4-(2-methoxyethoxy)benzoate|1012057-39-4|SCHEMBL643931|ethyl3-hydroxy-4-(2-methoxyethoxy)benzoate|CS-0163956|Ethyl 3-hydroxy-4-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),240.250,C12H16O5,65.000,231.000,1.600,17,1,5,7,"InChI=1S/C12H16O5/c1-3-16-12(14)9-4-5-11(10(13)8-9)17-7-6-15-2/h4-5,8,13H,3,6-7H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1)OCCOC)O,SSDWTFLWAPVQMN-UHFFFAOYSA-N,ethyl 3-hydroxy-4-(2-methoxyethoxy)benzoate,240.09977361,240.09977361,0,1,0,0,0,0,0,0,0,0,52,10,"",Patents,1,"",20120820,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|Chemhere|Chemieliva Pharmaceutical Co., Ltd|CymitQuimica|Google Patents|IBM|PATENTSCOPE (WIPO)|SCRIPDB|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
141500641,CID 141500641,"CS-0163996|3,4-bis(2-methoxyethoxy)-2-nitrobenzonitrile? (Erlotinib Impurity pound(c)",296.280,C13H16N2O6,107.000,363.000,1.100,21,0,7,8,"InChI=1S/C13H16N2O6/c1-18-5-7-20-11-4-3-10(9-14)12(15(16)17)13(11)21-8-6-19-2/h3-4H,5-8H2,1-2H3",COCCOC1=C(C(=C(C=C1)C#N)[N+](=O)[O-])OCCOC,QFGCBXBJWYXJFZ-UHFFFAOYSA-N,"3,4-bis(2-methoxyethoxy)-2-nitrobenzonitrile",296.10083623,296.10083623,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20191206,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
23033009,"2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid","574738-66-2|2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid|2-Amino-4,5-bis-(2-methoxy-ethoxy)-benzoic acid >98%|2-Amino-4,5-bis-(2-methoxy-ethoxy)-benzoic acid|SCHEMBL263684|DTXSID10629923|HUJDMSWRGMPHJD-UHFFFAOYSA-N|4,5-bis(2-methoxyethoxy)anthranilic acid|DB-292694|CS-0163994|2-amino-4,5-bis(2-methoxyethoxy)benzoic acid? (Erlotinib Impurity pound(c)",285.290,C13H19NO6,100.000,288.000,1.000,20,2,7,9,"InChI=1S/C13H19NO6/c1-17-3-5-19-11-7-9(13(15)16)10(14)8-12(11)20-6-4-18-2/h7-8H,3-6,14H2,1-2H3,(H,15,16)",COCCOC1=C(C=C(C(=C1)C(=O)O)N)OCCOC,HUJDMSWRGMPHJD-UHFFFAOYSA-N,"2-amino-4,5-bis(2-methoxyethoxy)benzoic acid",285.12123733,285.12123733,0,1,0,0,0,0,0,0,0,0,25,10,"",Patents,1,"",20071205,"AbaChemScene|AiFChem, an XtalPi Company|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|EPA DSSTox|EvitaChem|Google Patents|IBM|J&H Chemical Co.,ltd|NextMove Software|PATENTSCOPE (WIPO)|RR Scientific|Smolecule|SureChEMBL|THE BioTek|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
18925049,[7-(2-Chloro-ethoxy)-6-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine Hydrochloride,183320-19-6|[7-(2-Chloro-ethoxy)-6-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine Hydrochloride|7-(2-Chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine hydrochloride|7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|7-O-Desmethoxy-7-O-chloroethyl Erlotinib Hydrochloride|GBQJODHTQRFZEL-UHFFFAOYSA-N|7-(2-Chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)-4-quinazolinamine  Hydrochloride (1:1);|SCHEMBL3258381,434.300,C21H21Cl2N3O3,65.500,514.000,"",29,2,6,10,"InChI=1S/C21H20ClN3O3.ClH/c1-3-15-5-4-6-16(11-15)25-21-17-12-19(28-10-9-26-2)20(27-8-7-22)13-18(17)23-14-24-21;/h1,4-6,11-14H,7-10H2,2H3,(H,23,24,25);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCCl.Cl,GBQJODHTQRFZEL-UHFFFAOYSA-N,7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)quinazolin-4-amine;hydrochloride,433.0959969,433.0959969,0,2,0,0,0,0,0,0,0,0,24,3,"",Patents,1,"",20071204,"001Chemical|A2B Chem|BenchChem|BLD Pharm|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|CymitQuimica|EvitaChem|Google Patents|Hairui Chemical|LGC Standards|MolCore|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|RR Scientific|Smolecule|SureChEMBL|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
141273049,"Benzoic acid, 3-amino-4,5-bis(2-methoxyethoxy)-, ethyl ester","Benzoic acid, 3-amino-4,5-bis(2-methoxyethoxy)-, ethyl ester|2518426-66-7|ETHYL 3-AMINO-4,5-BIS(2-METHOXYETHOXY)BENZOATE|CS-0163941|F88808|Ethyl 3-amino-4,5-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)",313.350,C15H23NO6,89.200,314.000,1.100,22,1,7,11,"InChI=1S/C15H23NO6/c1-4-20-15(17)11-9-12(16)14(22-8-6-19-3)13(10-11)21-7-5-18-2/h9-10H,4-8,16H2,1-3H3",CCOC(=O)C1=CC(=C(C(=C1)OCCOC)OCCOC)N,RNZMLBGPFACHGW-UHFFFAOYSA-N,"ethyl 3-amino-4,5-bis(2-methoxyethoxy)benzoate",313.15253745,313.15253745,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20191206,"10X CHEM|A2B Chem|AA BLOCKS|AbaChemScene|Accel Scientific|AiFChem, an XtalPi Company|AppChem|Aribo Reagent|AstaTech, Inc.|BLD Pharm|eNovation Chemicals|EvitaChem|LGC Standards|Mcule|Molport|PATENTSCOPE (WIPO)|SynHet - Synthetic Heterocycles",Chemical Vendors|Governmental Organizations,""
53260313,"6,7-Bis(2-methoxyethoxy)-4-methoxyquinazoline","4-methoxy-6,7-bis(2-methoxyethoxy)quinazoline|1312937-41-9|6,7-bis(2-methoxyethoxy)-4-methoxyquinazoline|SCHEMBL1983663|DTXSID601253688|CS-0163977|4-methoxy-6,7-bis(2-methoxyethoxy)quinazoline? (Erlotinib Impurity pound(c)|Quinazoline, 4-methoxy-6,7-bis(2-methoxyethoxy)- (ACI); 4-Methoxy-6,7-bis(2-methoxyethoxy)quinazoline (ACI)",308.330,C15H20N2O5,71.900,308.000,1.500,22,0,7,9,"InChI=1S/C15H20N2O5/c1-18-4-6-21-13-8-11-12(16-10-17-15(11)20-3)9-14(13)22-7-5-19-2/h8-10H,4-7H2,1-3H3",COCCOC1=C(C=C2C(=C1)C(=NC=N2)OC)OCCOC,YPVDVZLVFQPRHS-UHFFFAOYSA-N,"4-methoxy-6,7-bis(2-methoxyethoxy)quinazoline",308.13722174,308.13722174,0,1,0,0,0,0,0,0,0,0,3,2,"",Patents,1,"",20110801,"AbaChemScene|BenchChem|BLD Pharm|Chemhere|Chemieliva Pharmaceutical Co., Ltd|CymitQuimica|EPA DSSTox|EvitaChem|Google Patents|IBM|LGC Standards|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
136360177,"4-((3-Ethynylphenyl)amino)quinazoline-6,7-diol hydrochloride","4-((3-Ethynylphenyl)amino)quinazoline-6,7-diol hydrochloride|1034651-72-3|SCHEMBL3873473|RMCPBZLFTGFFTQ-UHFFFAOYSA-N|CS-0163988|4-((3-Ethynylphenyl)amino)quinazoline-6,7-diolhydrochloride|N-(3-ethynylphenyl)-6,7-dihydroxy-4-quinazolinamine hydrochloride|4-((3-ethynylphenyl)amino)quinazoline-6,7-diol hydrochloride? (Erlotinib Impurity pound(c)",313.740,C16H12ClN3O2,78.300,408.000,"",22,4,5,3,"InChI=1S/C16H11N3O2.ClH/c1-2-10-4-3-5-11(6-10)19-16-12-7-14(20)15(21)8-13(12)17-9-18-16;/h1,3-9,20-21H,(H,17,18,19);1H",C#CC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)O)O.Cl,RMCPBZLFTGFFTQ-UHFFFAOYSA-N,"4-(3-ethynylanilino)quinazoline-6,7-diol;hydrochloride",313.0618043,313.0618043,0,2,0,0,0,0,0,0,0,0,13,3,"",Patents,1,"",20190123,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|Google Patents|NextMove Software|PATENTSCOPE (WIPO)|Starshine Chemical|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
135121329,"Ethly-3,4-bis(2-methoxyethoxy)-2-nitrobenzoate","CS-0163926|G15700|ETHLY-3,4-BIS(2-METHOXYETHOXY)-2-NITROBENZOATE|Ethyl 3,4-bis(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c)|2732925-07-2",343.330,C15H21NO8,109.000,386.000,1.600,24,0,8,11,"InChI=1S/C15H21NO8/c1-4-22-15(17)11-5-6-12(23-9-7-20-2)14(13(11)16(18)19)24-10-8-21-3/h5-6H,4,7-10H2,1-3H3",CCOC(=O)C1=C(C(=C(C=C1)OCCOC)OCCOC)[N+](=O)[O-],VARVSANQSFVBDU-UHFFFAOYSA-N,"ethyl 3,4-bis(2-methoxyethoxy)-2-nitrobenzoate",343.12671663,343.12671663,0,1,0,0,0,0,0,0,0,0,1,1,"",Patents,1,"",20181204,"AbaChemScene|Acorn PharmaTech Product List|AstaTech, Inc.|Google Patents|Lan Pharmatech|Molport|PATENTSCOPE (WIPO)",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,""
138113321,2-((4-Chloro-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol,CS-0163979|2-((4-Chloro-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol|2-((4-chloro-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethanol? (Erlotinib Impurity pound(c),298.720,C13H15ClN2O4,73.700,285.000,1.600,20,1,6,7,"InChI=1S/C13H15ClN2O4/c1-18-4-5-20-12-7-10-9(13(14)16-8-15-10)6-11(12)19-3-2-17/h6-8,17H,2-5H2,1H3",COCCOC1=C(C=C2C(=C1)N=CN=C2Cl)OCCO,XUKHUTSQIJGPMX-UHFFFAOYSA-N,2-[4-chloro-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol,298.0720347,298.0720347,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20190508,AbaChemScene|BLD Pharm|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
141408905,"3-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-imine","CS-0163999|3-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4(3H)-imine? (Erlotinib Impurity pound(c)",393.400,C22H23N3O4,76.400,616.000,2.400,29,1,6,10,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-15-24-19-14-21(29-11-9-27-3)20(28-10-8-26-2)13-18(19)22(25)23/h1,5-7,12-15,23H,8-11H2,2-3H3",COCCOC1=C(C=C2C(=C1)C(=N)N(C=N2)C3=CC=CC(=C3)C#C)OCCOC,YCLWJNRTROSZJD-UHFFFAOYSA-N,"3-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-imine",393.16885622,393.16885622,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20191206,AbaChemScene|PATENTSCOPE (WIPO),Chemical Vendors|Governmental Organizations,""
136156111,4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinol,183320-72-1|4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinol|4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-ol|4-((3-Ethynylphenyl)amino)-6-(2-methoxyethoxy)quinazolin-7-ol|Des-7-methoxyethanol erlotinib|SCHEMBL1507585|IHA32072,335.400,C19H17N3O3,76.500,466.000,3.100,25,2,6,7,"InChI=1S/C19H17N3O3/c1-3-13-5-4-6-14(9-13)22-19-15-10-18(25-8-7-24-2)17(23)11-16(15)20-12-21-19/h1,4-6,9-12,23H,7-8H2,2H3,(H,20,21,22)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)O,QRZXFNFMRVWNDG-UHFFFAOYSA-N,4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-ol,335.12699141,335.12699141,0,1,0,0,0,0,0,0,0,0,23,4,"",Patents,1,"",20190121,"001Chemical|AiFChem, an XtalPi Company|BenchChem|Biosynth|BLD Pharm|CymitQuimica|EvitaChem|Google Patents|Hairui Chemical|IBM|MolCore|PATENTSCOPE (WIPO)|Pharmacore Co., Limited|Smolecule|Starshine Chemical|SureChEMBL|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,""
135121327,"Ethyl 2-amino-3,4-bis(2-methoxyethoxy)benzoate","ethyl 2-amino-3,4-bis(2-methoxyethoxy)benzoate|CS-0163940|Ethyl 2-amino-3,4-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity)|2512209-22-0",313.350,C15H23NO6,89.200,314.000,1.700,22,1,7,11,"InChI=1S/C15H23NO6/c1-4-20-15(17)11-5-6-12(21-9-7-18-2)14(13(11)16)22-10-8-19-3/h5-6H,4,7-10,16H2,1-3H3",CCOC(=O)C1=C(C(=C(C=C1)OCCOC)OCCOC)N,ZGDZSCJBDKQAMF-UHFFFAOYSA-N,"ethyl 2-amino-3,4-bis(2-methoxyethoxy)benzoate",313.15253745,313.15253745,0,1,0,0,0,0,0,0,0,0,0,0,"",Patents,1,"",20181204,"AbaChemScene|Acorn PharmaTech Product List|AiFChem, an XtalPi Company|BLD Pharm|BOC Sciences|Lan Pharmatech|LGC Standards|PATENTSCOPE (WIPO)",Chemical Vendors|Governmental Organizations|Legacy Depositors,""
154630287,"N-(3-Ethynylphenyl)-7,8-bis(2-methoxyethoxy)quinazolin-4-amine","2410548-57-9|N-(3-Ethynylphenyl)-7,8-bis(2-methoxyethoxy)quinazolin-4-amine|CS-0163955|N-(3-Ethynylphenyl)-7,8-bis(2-methoxyethoxy)-4-quinazolinamine|N-(3-Ethynylphenyl)-7,8-bis(2-methoxyethoxy)quinazolin-4-amine (Erlotinib Impurity pound(c)",393.400,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(14-16)25-22-18-8-9-19(28-12-10-26-2)21(29-13-11-27-3)20(18)23-15-24-22/h1,5-9,14-15H,10-13H2,2-3H3,(H,23,24,25)",COCCOC1=C(C2=C(C=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,OMWZPNAQCXESNS-UHFFFAOYSA-N,"N-(3-ethynylphenyl)-7,8-bis(2-methoxyethoxy)quinazolin-4-amine",393.16885622,393.16885622,0,1,0,0,0,0,0,0,0,0,2,2,"",Patents,1,"",20200928,"A2B Chem|AA BLOCKS|AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|Google Patents|LGC Standards|PATENTSCOPE (WIPO)|Pharmacore Co., Limited",Chemical Vendors|Governmental Organizations|Research and Development,""
57369372,"OSI-420-d4, Free Base (Desmethyl Erlotinib-d4)","1216420-11-9|OSI-420-d4, Free Base (Desmethyl Erlotinib-d4)|Desmethyl Erlotinib-d4|2-[7-(2-methoxyethoxy)-4-(2,3,4,6-tetradeuterio-5-ethynylanilino)quinazolin-6-yl]oxyethanol|HY-13256AS|CS-0200826|G14538",383.400,C21H21N3O4,85.700,511.000,2.800,28,2,7,10,"InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)/i4D,5D,6D,11D",[2H]C1=C(C(=C(C(=C1[2H])NC2=NC=NC3=CC(=C(C=C32)OCCO)OCCOC)[2H])C#C)[2H],KOQIAZNBAWFSQM-GTNXRJHWSA-N,"2-[7-(2-methoxyethoxy)-4-(2,3,4,6-tetradeuterio-5-ethynylanilino)quinazolin-6-yl]oxyethanol",383.17831314,383.17831314,0,1,4,0,0,0,0,0,0,0,0,0,"","",0,"",20120712,"10X CHEM|A2B Chem|AbaChemScene|Alsachim|Ambinter|AstaTech, Inc.|BenchChem|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemTik|Clinivex|CymitQuimica|eMolecules|EvitaChem|InvivoChem|LGC Standards|MedChemexpress MCE|Molport|MuseChem|Smolecule|THE BioTek|Yuhao Chemical",Chemical Vendors|Legacy Depositors,""
169437612,N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib Hydrochloride-D6,N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib Hydrochloride-D6,490.800,C20H23BrClN3O4,74.700,448.000,"",29,2,7,10,"InChI=1S/C20H22BrN3O4.ClH/c1-25-6-8-27-18-11-16-17(12-19(18)28-9-7-26-2)22-13-23-20(16)24-15-5-3-4-14(21)10-15;/h3-5,10-13H,6-9H2,1-2H3,(H,22,23,24);1H/i1D3,2D3;",[2H]C([2H])([2H])OCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCCOC([2H])([2H])[2H].Cl,KEVQIMOUSDOXMB-TXHXQZCNSA-N,"N-(3-bromophenyl)-6,7-bis[2-(trideuteriomethoxy)ethoxy]quinazolin-4-amine;hydrochloride",489.09371,489.09371,0,2,6,0,0,0,0,0,0,0,0,0,"","",0,"",20231201,LGC Standards,Chemical Vendors,""
139210856,(Z)-3-(2-Bromovinyl)aniline (Erlotinib Impurity pound(c),CS-0163949|(Z)-3-(2-Bromovinyl)aniline (Erlotinib Impurity pound(c),198.060,C8H8BrN,26.000,122.000,2.200,10,1,1,1,"InChI=1S/C8H8BrN/c9-5-4-7-2-1-3-8(10)6-7/h1-6H,10H2/b5-4-",C1=CC(=CC(=C1)N)/C=C\Br,GZNZERVXZPXKHF-PLNGDYQASA-N,3-[(Z)-2-bromoethenyl]aniline,196.98401,196.98401,0,1,0,0,0,0,1,1,0,0,0,0,"","",0,"",20191011,AbaChemScene|Lan Pharmatech,Chemical Vendors|Legacy Depositors,""
162641319,Tetrahydro Erlotinib-d9,Tetrahydro Erlotinib-d9|HY-142493S|CS-0372533,406.500,C22H27N3O4,74.700,456.000,3.900,29,1,7,11,"InChI=1S/C22H27N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h5-7,12-15H,4,8-11H2,1-3H3,(H,23,24,25)/i1D3,4D2,5D,6D,7D,12D",[2H]C1=C(C(=C(C(=C1[2H])NC2=NC=NC3=CC(=C(C=C32)OCCOC)OCCOC)[2H])C([2H])([2H])C([2H])([2H])[2H])[2H],NUQUOVYZADJDTI-SATFOYSZSA-N,"6,7-bis(2-methoxyethoxy)-N-[2,3,4,6-tetradeuterio-5-(1,1,2,2,2-pentadeuterioethyl)phenyl]quinazolin-4-amine",406.25664706,406.25664706,0,1,9,0,0,0,0,0,0,0,0,0,"","",0,"",20220315,AbaChemScene|LGC Standards|MedChemexpress MCE,Chemical Vendors,""
163197314,7-(2-Chloroethoxy)-6-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),CS-0163943|7-(2-Chloroethoxy)-6-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),298.720,C13H15ClN2O4,69.200,353.000,1.100,20,1,5,7,"InChI=1S/C13H15ClN2O4/c1-18-4-5-20-11-6-9-10(15-8-16-13(9)17)7-12(11)19-3-2-14/h6-8H,2-5H2,1H3,(H,15,16,17)",COCCOC1=C(C=C2C(=C1)C(=O)NC=N2)OCCCl,DGLOJUSGATYIIW-UHFFFAOYSA-N,7-(2-chloroethoxy)-6-(2-methoxyethoxy)-3H-quinazolin-4-one,298.0720347,298.0720347,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197317,7-Hydroxy-6-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),CS-0163947|7-Hydroxy-6-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),236.220,C11H12N2O4,80.200,308.000,0.200,17,2,5,4,"InChI=1S/C11H12N2O4/c1-16-2-3-17-10-4-7-8(5-9(10)14)12-6-13-11(7)15/h4-6,14H,2-3H2,1H3,(H,12,13,15)",COCCOC1=C(C=C2C(=C1)C(=O)NC=N2)O,YTUCJXRPULWYBH-UHFFFAOYSA-N,7-hydroxy-6-(2-methoxyethoxy)-3H-quinazolin-4-one,236.07970687,236.07970687,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197299,Ethyl 3-(2-chloroethoxy)-4-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),CS-0163919|Ethyl 3-(2-chloroethoxy)-4-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),302.750,C14H19ClO5,54.000,274.000,2.800,20,0,5,10,"InChI=1S/C14H19ClO5/c1-3-18-14(16)11-4-5-12(20-9-8-17-2)13(10-11)19-7-6-15/h4-5,10H,3,6-9H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1)OCCOC)OCCCl,KHWXPGIAIDHBFP-UHFFFAOYSA-N,ethyl 3-(2-chloroethoxy)-4-(2-methoxyethoxy)benzoate,302.0921014,302.0921014,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197301,"Ethyl 3,4-bis(2-chloroethoxy)benzoate (Erlotinib Impurity pound(c)","CS-0163921|Ethyl 3,4-bis(2-chloroethoxy)benzoate (Erlotinib Impurity pound(c)",307.170,C13H16Cl2O4,44.800,263.000,3.500,19,0,4,9,"InChI=1S/C13H16Cl2O4/c1-2-17-13(16)10-3-4-11(18-7-5-14)12(9-10)19-8-6-15/h3-4,9H,2,5-8H2,1H3",CCOC(=O)C1=CC(=C(C=C1)OCCCl)OCCCl,ANVBAPYDHPITFX-UHFFFAOYSA-N,"ethyl 3,4-bis(2-chloroethoxy)benzoate",306.0425644,306.0425644,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197303,Ethyl 4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),CS-0163925|Ethyl 4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),329.300,C14H19NO8,120.000,372.000,1.100,23,1,8,10,"InChI=1S/C14H19NO8/c1-3-21-14(17)10-8-12(23-7-6-20-2)13(22-5-4-16)9-11(10)15(18)19/h8-9,16H,3-7H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1[N+](=O)[O-])OCCO)OCCOC,YBDRMUZJDKPNJM-UHFFFAOYSA-N,ethyl 4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)-2-nitrobenzoate,329.11106656,329.11106656,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197312,"6,7-Bis(2-methoxyethoxy)-2-methylquinazolin-4(3H)-one (Erlotinib Impurity pound(c)","CS-0163937|6,7-Bis(2-methoxyethoxy)-2-methylquinazolin-4(3H)-one (Erlotinib Impurity pound(c)",308.330,C15H20N2O5,78.400,401.000,0.300,22,1,6,8,"InChI=1S/C15H20N2O5/c1-10-16-12-9-14(22-7-5-20-3)13(21-6-4-19-2)8-11(12)15(18)17-10/h8-9H,4-7H2,1-3H3,(H,16,17,18)",CC1=NC2=CC(=C(C=C2C(=O)N1)OCCOC)OCCOC,FGPCHEUJFYODIL-UHFFFAOYSA-N,"6,7-bis(2-methoxyethoxy)-2-methyl-3H-quinazolin-4-one",308.13722174,308.13722174,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197315,6-(2-Hydroxyethoxy)-7-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),CS-0163944|6-(2-Hydroxyethoxy)-7-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),280.280,C13H16N2O5,89.400,350.000,-0.200,20,2,6,7,"InChI=1S/C13H16N2O5/c1-18-4-5-20-12-7-10-9(13(17)15-8-14-10)6-11(12)19-3-2-16/h6-8,16H,2-5H2,1H3,(H,14,15,17)",COCCOC1=C(C=C2C(=C1)N=CNC2=O)OCCO,QJFIGUITXBLAKK-UHFFFAOYSA-N,6-(2-hydroxyethoxy)-7-(2-methoxyethoxy)-3H-quinazolin-4-one,280.10592162,280.10592162,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
49849307,Erlotinib-13C6,"Erlotinib-13C6|1211107-68-4|AKOS040754923|HY-50896S1|CS-0203796|N-(5-ethynyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",399.390,C22H23N3O4,74.700,525.000,3.300,29,1,7,11,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)/i5+1,6+1,7+1,12+1,16+1,17+1",COCCOC1=C(C=C2C(=C1)C(=NC=N2)N[13C]3=[13CH][13CH]=[13CH][13C](=[13CH]3)C#C)OCCOC,AAKJLRGGTJKAMG-GQGGUIAASA-N,"N-(5-ethynyl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",399.18898524,399.18898524,0,1,6,0,0,0,0,0,0,0,0,0,"","",0,"",20110201,"AbaChemScene|AKos Consulting & Solutions|Alsachim|Amadis Chemical|BenchChem|BLD Pharm|BOC Sciences|Chemieliva Pharmaceutical Co., Ltd|Clearsynth|Debye Scientific Co., Ltd|EPA DSSTox|EvitaChem|Google Patents|InvivoChem|LGC Standards|MedChemexpress MCE|MuseChem|Smolecule|TargetMol|THE BioTek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,""
169440220,Erlotinib Ethyl Hydroxide,Erlotinib Ethyl Hydroxide,383.400,C21H25N3O4,85.700,442.000,3.300,28,2,7,10,"InChI=1S/C21H25N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(28-10-9-26-2)20(27-8-7-25)13-18(17)22-14-23-21/h4-6,11-14,25H,3,7-10H2,1-2H3,(H,22,23,24)",CCC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OCCOC)OCCO,PKGCQNQDVBNALO-UHFFFAOYSA-N,2-[4-(3-ethylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol,383.18450629,383.18450629,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20231201,BOC Sciences|LGC Standards,Chemical Vendors,""
139210858,"Ethyl 3,4-bis(2-methoxyethoxy)-5-nitrobenzoate (Erlotinib Impurity pound(c)","CS-0163927|Ethyl 3,4-bis(2-methoxyethoxy)-5-nitrobenzoate (Erlotinib Impurity pound(c)",343.330,C15H21NO8,109.000,386.000,1.600,24,0,8,11,"InChI=1S/C15H21NO8/c1-4-22-15(17)11-9-12(16(18)19)14(24-8-6-21-3)13(10-11)23-7-5-20-2/h9-10H,4-8H2,1-3H3",CCOC(=O)C1=CC(=C(C(=C1)OCCOC)OCCOC)[N+](=O)[O-],BGZTVZFNYDLGPM-UHFFFAOYSA-N,"ethyl 3,4-bis(2-methoxyethoxy)-5-nitrobenzoate",343.12671663,343.12671663,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20191011,AbaChemScene|Lan Pharmatech,Chemical Vendors|Legacy Depositors,""
149497994,"6,7-Bis(2-methoxyethoxy)-N,N-dimethylquinazolin-4-amine (Erlotinib Impurity)","CS-0163961|6,7-Bis(2-methoxyethoxy)-N,N-dimethylquinazolin-4-amine (Erlotinib Impurity)",321.370,C16H23N3O4,65.900,332.000,1.600,23,0,7,9,"InChI=1S/C16H23N3O4/c1-19(2)16-12-9-14(22-7-5-20-3)15(23-8-6-21-4)10-13(12)17-11-18-16/h9-11H,5-8H2,1-4H3",CN(C)C1=NC=NC2=CC(=C(C=C21)OCCOC)OCCOC,ZGKSZBRHXRWXJN-UHFFFAOYSA-N,"6,7-bis(2-methoxyethoxy)-N,N-dimethylquinazolin-4-amine",321.16885622,321.16885622,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20200812,AbaChemScene,Chemical Vendors,""
163197302,Ethyl 5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),CS-0163924|Ethyl 5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),329.300,C14H19NO8,120.000,372.000,1.100,23,1,8,10,"InChI=1S/C14H19NO8/c1-3-21-14(17)10-8-12(22-5-4-16)13(23-7-6-20-2)9-11(10)15(18)19/h8-9,16H,3-7H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1[N+](=O)[O-])OCCOC)OCCO,DXCYPGTVATVHGV-UHFFFAOYSA-N,ethyl 5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)-2-nitrobenzoate,329.11106656,329.11106656,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197308,"Ethyl 2-formamido-4,5-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)","CS-0163932|Ethyl 2-formamido-4,5-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)",341.360,C16H23NO7,92.300,366.000,1.500,24,1,7,12,"InChI=1S/C16H23NO7/c1-4-22-16(19)12-9-14(23-7-5-20-2)15(24-8-6-21-3)10-13(12)17-11-18/h9-11H,4-8H2,1-3H3,(H,17,18)",CCOC(=O)C1=CC(=C(C=C1NC=O)OCCOC)OCCOC,IRHQAIIOCXJIJZ-UHFFFAOYSA-N,"ethyl 2-formamido-4,5-bis(2-methoxyethoxy)benzoate",341.14745207,341.14745207,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene|SynHet - Synthetic Heterocycles,Chemical Vendors,""
163197309,"Ethyl (Z)-2-((aminomethylene)amino)-4,5-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)","CS-0163933|Ethyl (Z)-2-((aminomethylene)amino)-4,5-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)",340.370,C16H24N2O6,102.000,380.000,0.900,24,1,7,12,"InChI=1S/C16H24N2O6/c1-4-22-16(19)12-9-14(23-7-5-20-2)15(24-8-6-21-3)10-13(12)18-11-17/h9-11H,4-8H2,1-3H3,(H2,17,18)",CCOC(=O)C1=CC(=C(C=C1N=CN)OCCOC)OCCOC,GYNDGIRGIMVQHM-UHFFFAOYSA-N,"ethyl 2-(aminomethylideneamino)-4,5-bis(2-methoxyethoxy)benzoate",340.16343649,340.16343649,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197316,"7,8-Bis(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c)","CS-0163946|7,8-Bis(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c)",294.300,C14H18N2O5,78.400,363.000,0.400,21,1,6,8,"InChI=1S/C14H18N2O5/c1-18-5-7-20-11-4-3-10-12(15-9-16-14(10)17)13(11)21-8-6-19-2/h3-4,9H,5-8H2,1-2H3,(H,15,16,17)",COCCOC1=C(C2=C(C=C1)C(=O)NC=N2)OCCOC,MGFQBRLEMXHMDF-UHFFFAOYSA-N,"7,8-bis(2-methoxyethoxy)-3H-quinazolin-4-one",294.12157168,294.12157168,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197318,6-Hydroxy-7-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),CS-0163948|6-Hydroxy-7-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),236.220,C11H12N2O4,80.200,308.000,0.200,17,2,5,4,"InChI=1S/C11H12N2O4/c1-16-2-3-17-10-5-8-7(4-9(10)14)11(15)13-6-12-8/h4-6,14H,2-3H2,1H3,(H,12,13,15)",COCCOC1=C(C=C2C(=C1)N=CNC2=O)O,ODAQGVSBXRBSKB-UHFFFAOYSA-N,6-hydroxy-7-(2-methoxyethoxy)-3H-quinazolin-4-one,236.07970687,236.07970687,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197304,Ethyl 2-amino-5-hydroxy-4-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),CS-0163928|Ethyl 2-amino-5-hydroxy-4-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),255.270,C12H17NO5,91.000,261.000,1.500,18,2,6,7,"InChI=1S/C12H17NO5/c1-3-17-12(15)8-6-10(14)11(7-9(8)13)18-5-4-16-2/h6-7,14H,3-5,13H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1N)OCCOC)O,KMVROBDSGTYPPX-UHFFFAOYSA-N,ethyl 2-amino-5-hydroxy-4-(2-methoxyethoxy)benzoate,255.11067264,255.11067264,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197310,"4,4'-Oxybis(6,7-bis(2-methoxyethoxy)quinazoline) (Erlotinib Impurity pound(c)","CS-0163934|4,4'-Oxybis(6,7-bis(2-methoxyethoxy)quinazoline) (Erlotinib Impurity pound(c)",570.600,C28H34N4O9,135.000,657.000,2.600,41,0,13,18,"InChI=1S/C28H34N4O9/c1-33-5-9-37-23-13-19-21(15-25(23)39-11-7-35-3)29-17-31-27(19)41-28-20-14-24(38-10-6-34-2)26(40-12-8-36-4)16-22(20)30-18-32-28/h13-18H,5-12H2,1-4H3",COCCOC1=C(C=C2C(=C1)C(=NC=N2)OC3=NC=NC4=CC(=C(C=C43)OCCOC)OCCOC)OCCOC,RFEWFDKJISKAQX-UHFFFAOYSA-N,"4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]oxy-6,7-bis(2-methoxyethoxy)quinazoline",570.23257867,570.23257867,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197311,"6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[1,4'-biquinazolin]-4-one (Erlotinib Impurity pound(c)","CS-0163935|6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[1,4'-biquinazolin]-4-one (Erlotinib Impurity pound(c)",570.600,C28H34N4O9,132.000,809.000,1.700,41,0,11,17,"InChI=1S/C28H34N4O9/c1-34-5-9-38-23-13-19-21(15-25(23)40-11-7-36-3)29-17-30-27(19)32-18-31-28(33)20-14-24(39-10-6-35-2)26(16-22(20)32)41-12-8-37-4/h13-18H,5-12H2,1-4H3",COCCOC1=C(C=C2C(=C1)C(=NC=N2)N3C=NC(=O)C4=CC(=C(C=C43)OCCOC)OCCOC)OCCOC,OPKUJYBUDOTIEE-UHFFFAOYSA-N,"1-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-6,7-bis(2-methoxyethoxy)quinazolin-4-one",570.23257867,570.23257867,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197313,6-(2-Chloroethoxy)-7-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),CS-0163942|6-(2-Chloroethoxy)-7-(2-methoxyethoxy)quinazolin-4(3H)-one (Erlotinib Impurity pound(c),298.720,C13H15ClN2O4,69.200,353.000,1.100,20,1,5,7,"InChI=1S/C13H15ClN2O4/c1-18-4-5-20-12-7-10-9(13(17)16-8-15-10)6-11(12)19-3-2-14/h6-8H,2-5H2,1H3,(H,15,16,17)",COCCOC1=C(C=C2C(=C1)N=CNC2=O)OCCCl,YKLMFEYSUIYIBX-UHFFFAOYSA-N,6-(2-chloroethoxy)-7-(2-methoxyethoxy)-3H-quinazolin-4-one,298.0720347,298.0720347,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
154575121,Ethyl 4-hydroxy-5-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),CS-0163923|Ethyl 4-hydroxy-5-(2-methoxyethoxy)-2-nitrobenzoate (Erlotinib Impurity pound(c),285.250,C12H15NO7,111.000,330.000,1.400,20,1,7,7,"InChI=1S/C12H15NO7/c1-3-19-12(15)8-6-11(20-5-4-18-2)10(14)7-9(8)13(16)17/h6-7,14H,3-5H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1[N+](=O)[O-])O)OCCOC,QZOYDCXTOHMNLW-UHFFFAOYSA-N,ethyl 4-hydroxy-5-(2-methoxyethoxy)-2-nitrobenzoate,285.08485182,285.08485182,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20200904,AbaChemScene|Lan Pharmatech,Chemical Vendors|Legacy Depositors,""
163197300,Ethyl 4-(2-chloroethoxy)-3-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),CS-0163920|Ethyl 4-(2-chloroethoxy)-3-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),302.750,C14H19ClO5,54.000,274.000,2.800,20,0,5,10,"InChI=1S/C14H19ClO5/c1-3-18-14(16)11-4-5-12(19-7-6-15)13(10-11)20-9-8-17-2/h4-5,10H,3,6-9H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1)OCCCl)OCCOC,XEIPQUAIKOEDEM-UHFFFAOYSA-N,ethyl 4-(2-chloroethoxy)-3-(2-methoxyethoxy)benzoate,302.0921014,302.0921014,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197305,Ethyl 2-amino-4-hydroxy-5-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),CS-0163929|Ethyl 2-amino-4-hydroxy-5-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),255.270,C12H17NO5,91.000,261.000,1.500,18,2,6,7,"InChI=1S/C12H17NO5/c1-3-17-12(15)8-6-11(18-5-4-16-2)10(14)7-9(8)13/h6-7,14H,3-5,13H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1N)O)OCCOC,DEYXSAKNLITCPY-UHFFFAOYSA-N,ethyl 2-amino-4-hydroxy-5-(2-methoxyethoxy)benzoate,255.11067264,255.11067264,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
171714185,Desmethyl Erlotinib-d4-1,Desmethyl Erlotinib-d4-1|HY-13256AS1|CS-0437354,383.400,C21H21N3O4,85.700,511.000,2.800,28,2,7,10,"InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)/i7D2,8D2",[2H]C([2H])(C([2H])([2H])OC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC)O,KOQIAZNBAWFSQM-OSEHSPPNSA-N,"1,1,2,2-tetradeuterio-2-[4-(3-ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxyethanol",383.17831314,383.17831314,0,1,4,0,0,0,0,0,0,0,0,0,"","",0,"",20240704,AbaChemScene|MedChemexpress MCE,Chemical Vendors,""
162641167,N-(2-Methoxyethyl) Erlotinib-d3,N-(2-Methoxyethyl) Erlotinib-d3|HY-142207S|CS-0371229,449.600,C29H34O4,36.900,583.000,5.600,33,0,4,14,"InChI=1S/C29H34O4/c1-5-22-9-6-10-23(19-22)26(14-16-31-3)27-13-7-11-24-21-29(33-18-17-32-4)25(20-28(24)27)12-8-15-30-2/h1,6-7,9-11,13,19-21,26H,8,12,14-18H2,2-4H3/i3D3",[2H]C([2H])([2H])OCCC(C1=CC=CC(=C1)C#C)C2=CC=CC3=CC(=C(C=C32)CCCOC)OCCOC,ZOKRILASHZDHGT-HPRDVNIFSA-N,1-[1-(3-ethynylphenyl)-3-(trideuteriomethoxy)propyl]-6-(2-methoxyethoxy)-7-(3-methoxypropyl)naphthalene,449.26453980,449.26453980,0,1,3,1,0,1,0,0,0,0,0,0,"","",0,"",20220315,AbaChemScene|MedChemexpress MCE,Chemical Vendors,""
138112627,"N-(3-Ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hcl","1346601-52-2|N-(3-ETHYNYL-4-METHYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE HCL|N-(3-Ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride; N-(3-Ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride; 4-Methyl Erlotinib hydrochloride; Erlotinib 4-Methyl analog hydrochloride; N-[(3-Ethynyl-4-methyl)phenyl]-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Hydrochloride; OSI-597|NJJ9GW6WFR|F19462|N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|N-(3-ETHYNYL-4-METHYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINEHCL|2514264-76-5|4-Quinazolinamine, N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)",443.900,C23H26ClN3O4,74.700,554.000,"",31,2,7,11,"InChI=1S/C23H25N3O4.ClH/c1-5-17-12-18(7-6-16(17)2)26-23-19-13-21(29-10-8-27-3)22(30-11-9-28-4)14-20(19)24-15-25-23;/h1,6-7,12-15H,8-11H2,2-4H3,(H,24,25,26);1H",CC1=C(C=C(C=C1)NC2=NC=NC3=CC(=C(C=C32)OCCOC)OCCOC)C#C.Cl,KYYZCXHGUSHEAL-UHFFFAOYSA-N,"N-(3-ethynyl-4-methylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",443.1611840,443.1611840,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20190508,"AiFChem, an XtalPi Company|AstaTech, Inc.|BLD Pharm|eMolecules|FDA Global Substance Registration System (GSRS)|Hairui Chemical|LGC Standards|MolCore|Molport|Starshine Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations,""
11959870,"6,7-Bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine hydrochloride","1624294-38-7|6,7-Bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine hydrochloride|Erlotinib-3-vinyl Hydrochloride|N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|6,7-Bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine HCl|N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine Hydrochloride|7656QNB6CU|ZPC29438|4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride|DS-005524|CS-0163973|V10172|4-Quinazolinamine, N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride|4-Quinazolinamine, N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)|6,7-bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine hydrochloride? (Erlotinib Impurity pound(c)",431.900,C22H26ClN3O4,74.700,481.000,"",30,2,7,11,"InChI=1S/C22H25N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h4-7,12-15H,1,8-11H2,2-3H3,(H,23,24,25);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C=C)OCCOC.Cl,PVYZSHZFBOSTSM-UHFFFAOYSA-N,"N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",431.1611840,431.1611840,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20061211,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|Alichem|Amadis Chemical|Angel Pharmatech Ltd.|AstaTech, Inc.|BenchChem|BePharm Ltd.|Biosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|Combi-Blocks|CymitQuimica|Debye Scientific Co., Ltd|DiscoveryGate|FDA Global Substance Registration System (GSRS)|Hairui Chemical|LGC Standards|MolCore|Molecule Market|Molport|MuseChem|NextBio|OXCHEM CORPORATION|Smolecule|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,""
163197323,3-[4-Chloro-7-(2-methoxyethoxy)quinazolin-6-yl]oxypropanoate,CS-0163974|2-((4-chloro-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethyl formate? (Erlotinib Impurity pound(c),325.720,C14H14ClN2O5-,93.600,355.000,2.400,22,0,7,7,"InChI=1S/C14H15ClN2O5/c1-20-4-5-22-12-7-10-9(14(15)17-8-16-10)6-11(12)21-3-2-13(18)19/h6-8H,2-5H2,1H3,(H,18,19)/p-1",COCCOC1=C(C=C2C(=C1)N=CN=C2Cl)OCCC(=O)[O-],NOTPIWRSBBGUOK-UHFFFAOYSA-M,3-[4-chloro-7-(2-methoxyethoxy)quinazolin-6-yl]oxypropanoate,325.0591242,325.0591242,-1,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197325,3-[4-Chloro-6-(2-methoxyethoxy)quinazolin-7-yl]oxypropanoate,CS-0163975|2-((4-chloro-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethyl formate? (Erlotinib Impurity pound(c),325.720,C14H14ClN2O5-,93.600,355.000,2.400,22,0,7,7,"InChI=1S/C14H15ClN2O5/c1-20-4-5-22-11-6-9-10(16-8-17-14(9)15)7-12(11)21-3-2-13(18)19/h6-8H,2-5H2,1H3,(H,18,19)/p-1",COCCOC1=C(C=C2C(=C1)C(=NC=N2)Cl)OCCC(=O)[O-],HPUDWZGCXQFQMH-UHFFFAOYSA-M,3-[4-chloro-6-(2-methoxyethoxy)quinazolin-7-yl]oxypropanoate,325.0591242,325.0591242,-1,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197331,"8-chloro-N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride","CS-0163987|8-chloro-N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride? (Erlotinib Impurity pound(c)",464.300,C22H23Cl2N3O4,74.700,560.000,"",31,2,7,11,"InChI=1S/C22H22ClN3O4.ClH/c1-4-15-6-5-7-16(12-15)26-22-17-13-18(29-10-8-27-2)21(30-11-9-28-3)19(23)20(17)24-14-25-22;/h1,5-7,12-14H,8-11H2,2-3H3,(H,24,25,26);1H",COCCOC1=C(C(=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)Cl)OCCOC.Cl,LVGHHBSSEZTMNC-UHFFFAOYSA-N,"8-chloro-N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",463.1065616,463.1065616,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197333,"2-amino-N-formyl-4,5-bis(2-methoxyethoxy)benzamide;hydrochloride","CS-0163990|2-amino-N-formyl-4,5-bis(2-methoxyethoxy)benzamide hydrochloride? (Erlotinib Impurity pound(c)",348.780,C14H21ClN2O6,109.000,341.000,"",23,3,7,9,"InChI=1S/C14H20N2O6.ClH/c1-19-3-5-21-12-7-10(14(18)16-9-17)11(15)8-13(12)22-6-4-20-2;/h7-9H,3-6,15H2,1-2H3,(H,16,17,18);1H",COCCOC1=C(C=C(C(=C1)C(=O)NC=O)N)OCCOC.Cl,VOGIWFHEUWAISV-UHFFFAOYSA-N,"2-amino-N-formyl-4,5-bis(2-methoxyethoxy)benzamide;hydrochloride",348.1088141,348.1088141,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197335,Potassium;5-ethoxycarbonyl-2-(2-methoxyethoxy)phenolate,CS-0163991|potassium 5-(ethoxycarbonyl)-2-(2-methoxyethoxy)phenolate? (Erlotinib Impurity pound(c),278.340,C12H15KO5,67.800,237.000,"",18,0,5,7,"InChI=1S/C12H16O5.K/c1-3-16-12(14)9-4-5-11(10(13)8-9)17-7-6-15-2;/h4-5,8,13H,3,6-7H2,1-2H3;/q;+1/p-1",CCOC(=O)C1=CC(=C(C=C1)OCCOC)[O-].[K+],SVWDTCWZSWUYGN-UHFFFAOYSA-M,potassium;5-ethoxycarbonyl-2-(2-methoxyethoxy)phenolate,278.05565506,278.05565506,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197307,Ethyl 2-amino-4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)benzoate,Ethyl 2-amino-4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)benzoate|CS-0163931|Ethyl 2-amino-4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)|2514962-70-8,299.320,C14H21NO6,100.000,301.000,1.100,21,2,7,10,"InChI=1S/C14H21NO6/c1-3-19-14(17)10-8-12(21-7-6-18-2)13(9-11(10)15)20-5-4-16/h8-9,16H,3-7,15H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1N)OCCO)OCCOC,AGPJXKOJOKWDGO-UHFFFAOYSA-N,ethyl 2-amino-4-(2-hydroxyethoxy)-5-(2-methoxyethoxy)benzoate,299.13688739,299.13688739,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|LGC Standards",Chemical Vendors,""
163197339,"3-Amino-4,5-bis(2-methoxyethoxy)benzonitrile","CS-0163997|3-amino-4,5-bis(2-methoxyethoxy)benzonitrile? (Erlotinib Impurity pound(c)",266.290,C13H18N2O4,86.700,292.000,0.600,19,1,6,8,"InChI=1S/C13H18N2O4/c1-16-3-5-18-12-8-10(9-14)7-11(15)13(12)19-6-4-17-2/h7-8H,3-6,15H2,1-2H3",COCCOC1=CC(=CC(=C1OCCOC)N)C#N,QDLWPRVGEJIRRY-UHFFFAOYSA-N,"3-amino-4,5-bis(2-methoxyethoxy)benzonitrile",266.12665706,266.12665706,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197340,"2-Amino-3,4-bis(2-methoxyethoxy)benzonitrile","CS-0163998|2-amino-3,4-bis(2-methoxyethoxy)benzonitrile? (Erlotinib Impurity pound(c)",266.290,C13H18N2O4,86.700,292.000,1.200,19,1,6,8,"InChI=1S/C13H18N2O4/c1-16-5-7-18-11-4-3-10(9-14)12(15)13(11)19-8-6-17-2/h3-4H,5-8,15H2,1-2H3",COCCOC1=C(C(=C(C=C1)C#N)N)OCCOC,OSQDJNITDAWHRT-UHFFFAOYSA-N,"2-amino-3,4-bis(2-methoxyethoxy)benzonitrile",266.12665706,266.12665706,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197341,"Ethyl 3-Amino-4,5-bis(2-methoxyethoxy)benzoate Hydrochloride","CS-0164001|Ethyl 3-Amino-4,5-bis(2-methoxyethoxy)benzoate Hydrochloride|ethyl 3-amino-4,5-bis(2-methoxyethoxy)benzoate hydrochloride? (Erlotinib Impurity pound(c)|2518426-67-8",349.810,C15H24ClNO6,89.200,314.000,"",23,2,7,11,"InChI=1S/C15H23NO6.ClH/c1-4-20-15(17)11-9-12(16)14(22-8-6-19-3)13(10-11)21-7-5-18-2;/h9-10H,4-8,16H2,1-3H3;1H",CCOC(=O)C1=CC(=C(C(=C1)OCCOC)OCCOC)N.Cl,MKFCOYUVEJWJEU-UHFFFAOYSA-N,"ethyl 3-amino-4,5-bis(2-methoxyethoxy)benzoate;hydrochloride",349.1292152,349.1292152,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene|LGC Standards,Chemical Vendors,""
50849855,"3-(3-Aminophenyl)-2,3-dibromopropanoic acid","3-(3-aminophenyl)-2,3-dibromopropanoic acid|1239843-56-1|STL289848|AKOS005061604|CS-0163982|3-(3-Amino-phenyl)-2,3-dibromo-propionic acid? (Erlotinib Impurity pound(c)",322.980,C9H9Br2NO2,63.300,213.000,2.200,14,2,3,3,"InChI=1S/C9H9Br2NO2/c10-7(8(11)9(13)14)5-2-1-3-6(12)4-5/h1-4,7-8H,12H2,(H,13,14)",C1=CC(=CC(=C1)N)C(C(C(=O)O)Br)Br,YWKGMSUIJCYVNW-UHFFFAOYSA-N,"3-(3-aminophenyl)-2,3-dibromopropanoic acid",322.89795,320.90000,0,1,0,2,0,2,0,0,0,0,0,0,"","",0,"",20110222,"AbaChemScene|AiFChem, an XtalPi Company|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|DiscoveryGate|EDASA Scientific|Lan Pharmatech|Vitas-M Laboratory",Chemical Vendors|Legacy Depositors|Subscription Services,""
163197298,"2-Methoxyethyl 3,4-bis(2-methoxyethoxy)benzoate","2-Methoxyethyl 3,4-bis(2-methoxyethoxy)benzoate|1470063-78-5|DB-393356|CS-0163917|2-Methoxyethyl 3,4-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)",328.360,C16H24O7,72.500,311.000,1.500,23,0,7,13,"InChI=1S/C16H24O7/c1-18-6-9-21-14-5-4-13(16(17)23-11-8-20-3)12-15(14)22-10-7-19-2/h4-5,12H,6-11H2,1-3H3",COCCOC1=C(C=C(C=C1)C(=O)OCCOC)OCCOC,XYQBENITUNZROC-UHFFFAOYSA-N,"2-methoxyethyl 3,4-bis(2-methoxyethoxy)benzoate",328.15220310,328.15220310,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company|BLD Pharm|Debye Scientific Co., Ltd",Chemical Vendors,""
163197306,Ethyl 2-Amino-5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)benzoate,Ethyl 2-Amino-5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)benzoate|CS-0163930|Ethyl 2-amino-5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c)|2512209-18-4,299.320,C14H21NO6,100.000,301.000,1.100,21,2,7,10,"InChI=1S/C14H21NO6/c1-3-19-14(17)10-8-12(20-5-4-16)13(9-11(10)15)21-7-6-18-2/h8-9,16H,3-7,15H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1N)OCCOC)OCCO,FXIDLZXORVCLDW-UHFFFAOYSA-N,ethyl 2-amino-5-(2-hydroxyethoxy)-4-(2-methoxyethoxy)benzoate,299.13688739,299.13688739,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company|BOC Sciences|LGC Standards",Chemical Vendors,""
163197330,"N-[3-(1-chloroethenyl)phenyl]-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",2204518-92-1|N-(3-Desethynylphenyl)-N-(3-(1-chlorovinyl)phenyl) Erlotinib,429.900,C22H24ClN3O4,74.700,527.000,4.300,30,1,7,11,"InChI=1S/C22H24ClN3O4/c1-15(23)16-5-4-6-17(11-16)26-22-18-12-20(29-9-7-27-2)21(30-10-8-28-3)13-19(18)24-14-25-22/h4-6,11-14H,1,7-10H2,2-3H3,(H,24,25,26)",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C(=C)Cl)OCCOC,DQYGRMGDQBJQDP-UHFFFAOYSA-N,"N-[3-(1-chloroethenyl)phenyl]-6,7-bis(2-methoxyethoxy)quinazolin-4-amine",429.1455339,429.1455339,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,"AbaChemScene|BOC Sciences|Clearsynth|LGC Standards|Pharmacore Co., Limited",Chemical Vendors,""
148171546,"6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one","6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one|CS-0163952|6,6',7,7'-Tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one (Erlotinib Impurity pound(c)",570.600,C28H34N4O9,132.000,809.000,1.700,41,0,12,17,"InChI=1S/C28H34N4O9/c1-34-5-9-38-23-13-19-21(15-25(23)40-11-7-36-3)29-17-30-27(19)32-18-31-22-16-26(41-12-8-37-4)24(39-10-6-35-2)14-20(22)28(32)33/h13-18H,5-12H2,1-4H3",COCCOC1=C(C=C2C(=C1)C(=NC=N2)N3C=NC4=CC(=C(C=C4C3=O)OCCOC)OCCOC)OCCOC,KCQKELLDRSIAEQ-UHFFFAOYSA-N,"3-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-6,7-bis(2-methoxyethoxy)quinazolin-4-one",570.23257867,570.23257867,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20200812,"AbaChemScene|AiFChem, an XtalPi Company|LGC Standards|Pharmacore Co., Limited",Chemical Vendors,""
163197336,Potassium;4-ethoxycarbonyl-2-(2-methoxyethoxy)phenolate,CS-0163992|potassium 4-(ethoxycarbonyl)-2-(2-methoxyethoxy)phenolate? (Erlotinib Impurity pound(c),278.340,C12H15KO5,67.800,237.000,"",18,0,5,7,"InChI=1S/C12H16O5.K/c1-3-16-12(14)9-4-5-10(13)11(8-9)17-7-6-15-2;/h4-5,8,13H,3,6-7H2,1-2H3;/q;+1/p-1",CCOC(=O)C1=CC(=C(C=C1)[O-])OCCOC.[K+],DZHGTNINNCTMFC-UHFFFAOYSA-M,potassium;4-ethoxycarbonyl-2-(2-methoxyethoxy)phenolate,278.05565506,278.05565506,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197338,"3,4-Bis(2-methoxyethoxy)-5-nitrobenzonitrile","CS-0163995|3,4-Bis(2-methoxyethoxy)-5-nitrobenzonitrile|3,4-bis(2-methoxyethoxy)-5-nitrobenzonitrile? (Erlotinib Impurity pound(c)|180031-38-3",296.280,C13H16N2O6,107.000,363.000,1.100,21,0,7,8,"InChI=1S/C13H16N2O6/c1-18-3-5-20-12-8-10(9-14)7-11(15(16)17)13(12)21-6-4-19-2/h7-8H,3-6H2,1-2H3",COCCOC1=CC(=CC(=C1OCCOC)[N+](=O)[O-])C#N,JYGWTGFHJDXCCA-UHFFFAOYSA-N,"3,4-bis(2-methoxyethoxy)-5-nitrobenzonitrile",296.10083623,296.10083623,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,"AbaChemScene|AiFChem, an XtalPi Company",Chemical Vendors,""
127263953,"N-(3-Bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine HCl","2055840-41-8|N-(3-Bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine HCl|N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib Hydrochloride|N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|RB4Z6LE3U7|V10171|N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-aminehydrochloride|4-Quinazolinamine, N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)",484.800,C20H23BrClN3O4,74.700,448.000,"",29,2,7,10,"InChI=1S/C20H22BrN3O4.ClH/c1-25-6-8-27-18-11-16-17(12-19(18)28-9-7-26-2)22-13-23-20(16)24-15-5-3-4-14(21)10-15;/h3-5,10-13H,6-9H2,1-2H3,(H,22,23,24);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCCOC.Cl,KEVQIMOUSDOXMB-UHFFFAOYSA-N,"N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",483.05605,483.05605,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20170618,"10X CHEM|A2B Chem|AA BLOCKS|Alfa Chemistry|AstaTech, Inc.|BenchChem|BLD Pharm|Combi-Blocks|CymitQuimica|eMolecules|FDA Global Substance Registration System (GSRS)|LGC Standards|Molport|Sigma-Aldrich|Smolecule|Starshine Chemical|Synthink Research Chemicals|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors,""
163197329,"N-[3-(1-chloroethenyl)phenyl]-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride","CS-0163986|N-(3-(1-chlorovinyl)phenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride? (Erlotinib Impurity pound(c)",466.400,C22H25Cl2N3O4,74.700,527.000,"",31,2,7,11,"InChI=1S/C22H24ClN3O4.ClH/c1-15(23)16-5-4-6-17(11-16)26-22-18-12-20(29-9-7-27-2)21(30-10-8-28-3)13-19(18)24-14-25-22;/h4-6,11-14H,1,7-10H2,2-3H3,(H,24,25,26);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C(=C)Cl)OCCOC.Cl,IDDDGIRQAQLUIS-UHFFFAOYSA-N,"N-[3-(1-chloroethenyl)phenyl]-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",465.1222117,465.1222117,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197332,"Ethyl 2-amino-4,5-dihydroxybenzoate","CS-0163989|ethyl 2-amino-4,5-dihydroxybenzoate? (Erlotinib Impurity pound(c)",197.190,C9H11NO4,92.800,209.000,1.900,14,3,5,3,"InChI=1S/C9H11NO4/c1-2-14-9(13)5-3-7(11)8(12)4-6(5)10/h3-4,11-12H,2,10H2,1H3",CCOC(=O)C1=CC(=C(C=C1N)O)O,ITLDVLKAULYWLE-UHFFFAOYSA-N,"ethyl 2-amino-4,5-dihydroxybenzoate",197.06880783,197.06880783,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
163197337,"Potassium;3,4-bis(2-methoxyethoxy)benzoate","CS-0163993|potassium 3,4-bis(2-methoxyethoxy)benzoate? (Erlotinib Impurity pound(c)",308.370,C13H17KO6,77.100,263.000,"",20,0,6,9,"InChI=1S/C13H18O6.K/c1-16-5-7-18-11-4-3-10(13(14)15)9-12(11)19-8-6-17-2;/h3-4,9H,5-8H2,1-2H3,(H,14,15);/q;+1/p-1",COCCOC1=C(C=C(C=C1)C(=O)[O-])OCCOC.[K+],URKKIDSGARKXQV-UHFFFAOYSA-M,"potassium;3,4-bis(2-methoxyethoxy)benzoate",308.06621974,308.06621974,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
139034377,Ethyl 4-hydroxy-3-(2-methoxyethoxy)benzoate,Ethyl 4-hydroxy-3-(2-methoxyethoxy)benzoate|CS-0163957|Ethyl 4-hydroxy-3-(2-methoxyethoxy)benzoate (Erlotinib Impurity pound(c),240.250,C12H16O5,65.000,231.000,2.000,17,1,5,7,"InChI=1S/C12H16O5/c1-3-16-12(14)9-4-5-10(13)11(8-9)17-7-6-15-2/h4-5,8,13H,3,6-7H2,1-2H3",CCOC(=O)C1=CC(=C(C=C1)O)OCCOC,MQIJRRUJMBVHQW-UHFFFAOYSA-N,ethyl 4-hydroxy-3-(2-methoxyethoxy)benzoate,240.09977361,240.09977361,0,1,0,0,0,0,0,0,0,0,0,0,"","",0,"",20190929,"AbaChemScene|BLD Pharm|Pharmacore Co., Limited",Chemical Vendors,""
163197327,N-(3-ethynylphenyl)-7-methoxy-6-(2-methoxyethoxy)quinazolin-4-amine;hydrochloride,CS-0163983|N-(3-ethynylphenyl)-7-methoxy-6-(2-methoxyethoxy)quinazolin-4-amine hydrochloride? (Erlotinib Impurity pound(c),385.800,C20H20ClN3O3,65.500,480.000,"",27,2,6,8,"InChI=1S/C20H19N3O3.ClH/c1-4-14-6-5-7-15(10-14)23-20-16-11-19(26-9-8-24-2)18(25-3)12-17(16)21-13-22-20;/h1,5-7,10-13H,8-9H2,2-3H3,(H,21,22,23);1H",COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OC.Cl,TXSRYNGMIGERHA-UHFFFAOYSA-N,N-(3-ethynylphenyl)-7-methoxy-6-(2-methoxyethoxy)quinazolin-4-amine;hydrochloride,385.1193192,385.1193192,0,2,0,0,0,0,0,0,0,0,0,0,"","",0,"",20220430,AbaChemScene,Chemical Vendors,""
